EurekaMag.com logo
+ Translate

Biology, Geography & Health: Chapter 6096

Chapter 6096 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.



Namba, T.; Komatsu, K.; Mikage, M., 1986: Pharmacognostical studies on the chinese crude drug fu pen zi 3. botanical origin of fu pen zi from korea ii

Namba T.; Komatsu K.; Mikage M., 1987: Pharmacognostical studies on the chinese crude drug fu pen zi 5 botanical origin of fu pen zi from china mainland

Taki, K.; Yamazaki, F.; Mizuno, M.; Kubo, M., 1977: Pharmacognostical studies on the chinese crude drug gehua part 2 on the morphology of the pollen grains

Namba, T.; Takano, A.; Komatsu, K.; Mikage, M., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 1. the plant origin of pu gong ying from taiwan

Namba, T.; Takano, A.; Mikage, M., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 2. the plant origin of pu gong ying from taiwan

Namba, T.; Takano, A.; Mikage, M., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 3. on the general structure of underground parts of taraxacum plants and the botanical origin of hokoei from shikoku district japan


Takano, A.; Mikage, M.; Namba, T., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 4. on the botanical origin of hokoei from nagano and gunma prefectures japan

Ota, N.; Mino, Y.; Tanaka, K., 1982: Pharmacognostical studies on the chinese crude drug sophorae radix 2. on the crude drug sophorae radix from japan korea and china

Namba, T.; Kubo, M.; Mikage, M., 1976: Pharmacognostical studies on the chinese crude drug xia ku cao

Inagaki, K.; Nunome, S.; Namba, T., 1983: Pharmacognostical studies on the chinese crude drugs derived from insects 2. banmao

Namba, T.; Inagaki, K.; Nunome, S., 1983: Pharmacognostical studies on the chinese crude drugs derived from insects 3. hongniangzi

Namba T.; Shimizu M.; Inagaki K.; Namba K.; Nakamura H., 1982: Pharmacognostical studies on the chinese crude drugs derived from insects on mengchong

Namba, T.; Mikage, M.; Komatsu, K., 1982: Pharmacognostical studies on the chinese crude drugs di fu zi and chong wei zi 1. the crude drugs derived from leonurus

Kubo, M.; Katsuki, T.; Nagao, T.; Mizuno, M.; Ohashi, H., 1977: Pharmacognostical studies on the chinese crude drugs gehua

Ai T.; Zhang D.; Fu G.; Cheng Z.; Xie Z., 1987: Pharmacognostical studies on the chinese drug guanzhong produced in middle south china

Namba, T.; Mikage, M.; Komatsu, K.; Xu, L. S.; Xu, G. J., 1988: Pharmacognostical studies on the chinese drug jinyinhua iii. botanical origins of well circulating drug in china mainland

Shimomura, H.; Sashida, Y.; Takagishi, T.; Terakado, H., 1982: Pharmacognostical studies on the crude drug bai he 1. comparative studies on external structures

Shimomura, H.; Sashida, Y.; Takagishi, T.; Kishimoto, A.; Furuuchi, N., 1984: Pharmacognostical studies on the crude drug bai he 2. the characteristics of the internal structures

Okuno, I.; Okanishi, T.; Noro, Y.; Namba, T., 1980: Pharmacognostical studies on the crude drug inchinko in japan 4. capitulum of artemisia japonica and artemisia japonica ssp littoricola

Namba, T.; Okuno, I.; Noro, Y., 1982: Pharmacognostical studies on the crude drug inchinko in japan 5. morphological studies on the flower heads of japanese artemisia

Okuno, I.; Kagawa, K.; Noro, Y.; Namba, T., 1983: Pharmacognostical studies on the crude drug inchinko in japan 6. seasonal variation in chemical constituents of artemisia capillaris

Yamagata, E.; Yoneda, K., 1987: Pharmacognostical studies on the crude drug of agarwood vi. on kanankoh

Namba, T.; Bae, K. H.; Akai, K., 1980: Pharmacognostical studies on the crude drug zhu ye and bambusaceous plants 1. the crude drug dan zhu ye from china

Namba, T.; Bae, K., 1984: Pharmacognostical studies on the crude drug zhu ye and bambusaceous plants 9. keys for identification of the leaves of bambusaceous plants based on the anatomical characteristics

Namba, T.; Bae, K. H., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 2. on the botanical origins of the crude drug wa no tan chiku yo on the japanese markets and the crude drug juk yeup on the korean markets and the comparative anatomical studies on the leaves of the genus phyllostachys

Bae K.H.; Namba T., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 3 botanical origins of the crude drug juk yeup on the korean markets and the comparative anatomical studies of the leaves of the genera sasamorpha and pseudosasa

Bae, K. H.; Namba, T., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 4. botanical origins of the crude drug juk yeup on the korean markets and the comparative anatomical studies of the leaves of the genus pleioblastus

Namba, T.; Bae, K. H., 1982: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 4. the comparative anatomical studies on the leaves of the genera bambusa and dendrocalamus

Namba, T.; Bae, K. H., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 5. the comparative anatomical studies on the leaves of the genera semiarundinaria sinobambusa shibataea tetragonocalamus and chimonobambusa

Namba, T.; Bae, K. H., 1982: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 7. the botanical origins of the folk medicine kuma zasa on the japanese markets and the comparative anatomical studies of the leaves of the genus sasa sections sasa macrochlamys monilicladae and lasioderma

Bae, K. H.; Namba, T., 1982: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 8. the internal and surface structures of the leaves of the genus sasaella and the section crassinodi of the genus sasa

Namba, T.; Lin, C. C.; Kikuchi, T.; Kan, W. S., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 1. i tiam hong

Lin, C. C.; Namba, T., 1982: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 10. on koan lan hioh

Namba, T.; Lin, C. C.; Kan, W. S., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 2. i tiam hong

Namba, T.; Lin, C. C.; Kan, W. S., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 3. i tiam hong

Namba, T.; Lin, C. C., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 4. chioh hak 1

Namba, T.; Lin, C. C., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 5. chioh hak 2

Lin, C. C.; Namba, T., 1982: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 9. chheng thian liong thiau

Okada, M., 1976: Pharmacognostical studies on the genus rhamnus

Taki, K.; Yamazaki, F.; Mizuno, M., 1976: Pharmacognostical studies on the market articles hoo at hong kong

Konoshima, M.; Miyagawa, T., 1976: Pharmacognostical studies on the piperaceous plants 2 studies on the crude drugs of stems part 2 on the piper eupiper and cubeba sections and peperomia

Konoshima, M.; Miyagawa, T., 1976: Pharmacognostical studies on the piperaceous plants part 1 studies on the crude drugs of stems part 1 on the piper chavica section

Konoshima, M.; Miyagawa, T., 1977: Pharmacognostical studies on the piperaceous plants part 3 studies on the crude drugs of leaves

But P.P.H.; Ng G.K.H.; Kong Y.C., 1985: Pharmacognostical studies on the related articles of kudingcha in hong kong market

Mary, Z.; Yoganarasimhan, S. N.; Pattanshetty, J. K.; Nayar, R. C., 1977: Pharmacognostical studies on the root of apama siliquosa aristolochiaceae

Nayar, R. C.; Pattan-Shetty, J. K.; Mary, Z.; Yoganarasimhan, S. N., 1978: Pharmacognostical studies on the root of decalepis hamiltonii and comparison with hemidesmus indicus

Kohda H.; Satake M., 1983: Pharmacognostical studies on the umbelliferous crude drug qianghuo 1

Kohda, H.; Satake, M., 1982: Pharmacognostical studies on the umbelliferous crude drug qianhu 5. constituents of chinese qianhu

Namba, T.; Namba, K.; Kaneko, H.; Takahashi, S., 1976: Pharmacognostical studies on yen hu suo part 2 historical studies on yen hu suo in the chinese herbal and books of prescription part 2

Moustafa, S. M. I., 1986: Pharmacognostical study of fumaria densiflora dc part ii. leaf and flower

Mitra, R.; Srivastava, U. C., 1985: Pharmacognostical study of root bark of erythrina indica lam. paribhadra

Ghauri E.G., 1987: Pharmacognostical study on changeri

Shimomura H.; Sashida Y.; Tanaka T.; Nakamura M., 1986: Pharmacognostical study on the crude drug corni fructus shanzhuyu

Namba T.; Mikage M.; Komatsu K.; Takarada S.; Okuno I., 1984: Pharmacognostical study on the crude drug in jin go from korea

Tyler V.E.; Brady L.R.; Robbers J.E., 1976: Pharmacognosy

Nayar, R. C.; Yoganarasimhan, S. N.; Subramanyam, K., 1976: Pharmacognosy of a local market sample of bharangi pygmaeopremna herbacea

Datta S.K.; Datta P.C., 1982: Pharmacognosy of allamanda cathartica bark drugs

Datta S.K.; Datta P.C., 1984: Pharmacognosy of alstonia scholaris bark drugs

Sanyal M.; Datta P.C., 1981: Pharmacognosy of aphanamixis polystachya stem bark

Srivastava, G. N.; Srivastava, A. K., 1988: Pharmacognosy of catharanthus roseus l. g. don sadabahar root and its adulterants

Datta S.K.; Datta P.C., 1984: Pharmacognosy of streblus bark drug

Lal J.; Khan A.M., 1982: Pharmacognosy of the stems of portulaca quadrifida and portulaca oleracea

Guaglio R.; Rampini A.; Imo V., 1985: Pharmacognosy yesterday and today

Croteau D.; Bergeron M.G.; Lebel M., 1988: Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high pressure liquid chromatography

Johno, I.; Hasegawa, M.; Nakamura, T. A.; Ohshima, T.; Kitazawa, S.; Goto, M., 1986: Pharmacokinetic analyses and drug plasma level simulation by using a personal computer with unequal doses and dosing intervals

Ahmad T.; Khursheed S.M.; Aslam M., 1984: Pharmacokinetic analysis and calculations using a program for the minicomputer sharp pc 1500

Burchiel S.W.; Pollock R.R.; Covell D.G.; Fuller G.; Scharff M.D., 1987: Pharmacokinetic analysis of biosynthetically radiolabeled mouse monoclonal antibodies in normal rhesus monkey

Murata K.; Noda K.; Kohno K.; Samejima M., 1987: Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi fraction absorption models

Oku M.; Noda T.; Kiyozuka Y.; Ninomiya Y.; Hino K.; Okamura Y.; Maruyama M.; Ichijo M., 1988: Pharmacokinetic analysis of intraperitoneal cisplatinum administration

Jay W.M.; Aziz M.Z.; Rissing J.P.; Shockley R.K., 1985: Pharmacokinetic analysis of intravitreal ceftriaxone in monkeys

Tsuboi T.; Kokue E I.; Shimoda M.; Hayama T., 1984: Pharmacokinetic analysis of plasma concentration and urinary excretion of sulfamonomethoxine and its metabolite in goettingen minipigs

Hussein Z.; Bialer M.; Friedman M.; Raz I., 1987: Pharmacokinetic analysis of sustained release dosage forms of theophylline in humans comparison of single and multiple dose studies

Mehvar R.; Jamali F., 1988: Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs

Funaki T.; Furuta S.; Kaneniwa N., 1986: Pharmacokinetic analysis of the tubular secretion process of cimetidine in rats

Amlacher R.; Gira G., 1986: Pharmacokinetic analysis of two differently constructed dose schedules for antiviral in vivo screening procedures

Baret A.; Jadot G.; Michelson A.M., 1984: Pharmacokinetic and anti inflammatory properties in the rat of superoxide dismutases copper superoxide dismutase and manganese superoxide dismutase from various species

Mcgovren J.P.; Pratt E.A.; Belt R.J.; Taylor S.A.; Benjamin R.S.; Ardalan B.; Ohnuma T., 1985: Pharmacokinetic and biochemical studies on acivicin in phase i clinical trials

Toyonaga Y.; Sugita M.; Hori M., 1988: Pharmacokinetic and clinical evaluation of ceftriaxone in neonates and premature infants

Bergue P.C.; Baron S.; Challier P.; Fontaine J.L.; Lasfargues G., 1987: Pharmacokinetic and clinical evaluation of imipenem cilastatin in children and neonates

Pedraz J.L.; Lanao J.M.; Calvo M.B.; Muriel C.; Hernandez Arbeiza J.; Dominguez Gil A., 1987: Pharmacokinetic and clinical evaluation of ketamine administered by iv and epidural routes

Motohiro T.; Oda K.; Aramaki M.; Tanaka K.; Kawakami A.; Shimada Y.; Koga T.; Tomita S.; Sakata Y.; Et Al, 1988: Pharmacokinetic and clinical evaluations of ceftriaxone in neonates and premature infants

Matsumoto K.; Shishido H.; Takahashi A., 1985: Pharmacokinetic and clinical evaluations of micronomicin by intravenous drip infusion

Iwai N.; Nakamura H.; Miyazu M.; Katayama M.; Taneda Y., 1988: Pharmacokinetic and clinical evaluations on ceftriaxone in neonates

Shiro H.; Kusumoto Y.; Satoh Y.; Oikawa T.; Osano M., 1988: Pharmacokinetic and clinical evaluations on ceftriaxone in neonates and premature infants

Hosoda T.; Ichioka T.; Miyao M., 1987: Pharmacokinetic and clinical experience with flomoxef in bacterial infection of children

Ninomiya K.; Ohbayashi F.; Hasegawa Y.; Kanamoto T., 1986: Pharmacokinetic and clinical studies of cefotiam during the perinatal period in pregnant women

Nishimura T.; Tabuki K.; Takashima T., 1986: Pharmacokinetic and clinical studies of cefotiam in mature neonates

Toyonaga Y.; Sugita M.; Kurosu Y.; Hori M., 1986: Pharmacokinetic and clinical studies of cefotiam in neonates and premature infants

Cho N.; Fukunaga K.; Kunii K., 1986: Pharmacokinetic and clinical studies of cefotiam in perinatal period

Hayasaki M.; Hanabayashi T.; Ri J.; Takada Y.; Ito K.; Noda K.; IIda M.; Chan C.; Yamada Y.; Et Al, 1986: Pharmacokinetic and clinical studies of cefotiam in the perinatal period

Cho N.; Fukunaga K.; Kunii K., 1986: Pharmacokinetic and clinical studies of ceftazidime in perinatal period

Nishimura T.; Takashima T.; Tabuki K.; Takagi M., 1988: Pharmacokinetic and clinical studies of ceftriaxone in neonates

Iwai N.; Miyazu M.; Shibata M.; Nakamura H.; Katayama M.; Taneda Y.; Inokuma K., 1987: Pharmacokinetic and clinical studies of cefuzonam in pediatrics

Takaoka H.; Makinoda S.; Ichinoe K.; Kawaguchi I.; Nishiya M., 1988: Pharmacokinetic and clinical studies of cefuzonam in the field of obstetrics and gynecology

Motohiro T.; Koga T.; Shimada Y.; Tomita S.; Fujimoto T.; Nishiyama T.; Tominaga K.; Yamashita F.; Takajo N.; Et Al, 1987: Pharmacokinetic and clinical studies of cefuzonam in the pediatric field

Obata I.; Imagawa N.; Yokoyama S.; Koike K.; Morimoto O.; Hachiya S., 1986: Pharmacokinetic and clinical studies of imipenem cilastatin sodium in the field of obstetrics and gynecology

Motohiro T.; Koga T.; Shimada Y.; Tomita S.; Fujimoto T.; Nishiyama T.; Tominga K.; Yamashita F.; Suzuki K.; Et Al, 1986: Pharmacokinetic and clinical studies of imipenem cilastatin sodium in the pediatric field

Fujii R.; Hashira S.; Takimoto M.; Oka T.; Yoshioka H.; Tsuchida A.; Sanae N.; Maruyama S.; Tojo M.; Et Al, 1984: Pharmacokinetic and clinical studies of latamoxef moxalactam in neonates and premature infants

Takamizawa H.; Matsui H.; Kobayashi S.; Shimizu H.; Kato K.; Yamaga A.; Yamasawa K.; Suzuki S., 1987: Pharmacokinetic and clinical studies of the effectiveness of cefuzonam on obstetric and gynecologic infections

Nishimura T.; Tabuki K.; Takashima T., 1987: Pharmacokinetic and clinical studies on amikacin in neonates

Matsumoto T.; Yoshida T.; Ohura T.; Hoshi M.; Honda K.; Ohiwa A.; Ishikawa T.; Hasegawa T.; Sugano H.; Et Al, 1987: Pharmacokinetic and clinical studies on cefotaxime in plastic and reconstructive surgery

Yamamoto T.; Yasuda J.; Kanao M.; Okada H., 1986: Pharmacokinetic and clinical studies on cefotiam in the perinatal period

Obata I.; Koike K.; Morimoto O.; Hachiya S.; Yamato T.; Hayashi S.; Hayashi M., 1987: Pharmacokinetic and clinical studies on ceftriaxone in the field of obstetrics and gynecology

Hirabayashi K.; Okada E., 1988: Pharmacokinetic and clinical studies on ceftriaxone in the perinatal period

Cho N.; Fukunaga K.; Kunii K.; Kimura T.; Kameda S.; Watanabe H., 1987: Pharmacokinetic and clinical studies on cefuzonam in obstetrics and gynecology

Fujii R.; Et Al, 1986: Pharmacokinetic and clinical studies on cefuzonam in the pediatric field

Masahiro I.; Ihara T.; Kamiya H.; Sakurai M.; Shimizu S.; Nishi H.; Kawaguchi H.; Yoshizumi T.; Inoue M.; Kojima M., 1987: Pharmacokinetic and clinical studies on flomoxef in the pediatric field

Shindo K.; Oikawa N.; Chida S.; Tsuburaya T.; Sato M., 1987: Pharmacokinetic and clinical studies on latamoxef in the field of obstetrics and gynecology

Fujii R.; Meguro H.; Arimasu O.; Yoshioka H.; Fujita K.; Maruyama S.; Inyaku F.; Nagamatsu I.; Wagatsuma Y.; Et Al, 1986: Pharmacokinetic and clinical studies with imipenem cilastatin sodium in the pediatric field

Leucuta S.E.; Domsa Bologa L., 1987: Pharmacokinetic and clinical study of the action of metronidazole administered by rectal route

Keefer L.K.; Streeter A.J.; Leung L.Y.; Perry W.C.; Hu H.S W.; Baillie T.A., 1987: Pharmacokinetic and deuterium isotope effect studies on the metabolism of formaldehyde and formate to carbon dioxide in rats in vivo

Perren T.J.; Clayton R.N.; Blackledge G.; Bailey L.C.; Holder G.; Lynch S.S.; Arkell D.G.; Cottam J.; Farrar D.; Young C.H., 1986: Pharmacokinetic and endocrinological parameters of a slow release depot preparation of the gonadotropin releasing hormone analogue ici 118630 zoladex compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer

Girard A.E.; Girard D.; English A.R.; Gootz T.D.; Cimochowski C.R.; Faiella J.A.; Haskell S.L.; Retsema J.A., 1987: Pharmacokinetic and in vivo studies with azithromycin cp 62993 a new macrolide with an extended half life and excellent tissue distribution

Schauder P., 1985: Pharmacokinetic and metabolic interrelationships among branched chain keto and amino acids in humans

Szeleczky, G.; Vereczkey, L., 1986: Pharmacokinetic and metabolic studies of vinpocetine on dogs i. pharmacokinetics

Szeleczky, G.; Vereczkey, L., 1986: Pharmacokinetic and metabolic studies of vinpocetine on dogs ii. metabolism

Lautier J.; Chanal J L.; Delhon A., 1986: Pharmacokinetic and metabolic study of itanoxone in the crab pachygrapsus marmoratus decapoda brachyura comparative study with clofibric acid

Noker P.E.; Hill D.L.; Kalin J.R.; Temple C.G.Jr; Montgomery J.A., 1985: Pharmacokinetic and metabolism studies of two novel 1 deaza 7 8 dihydropteridines in mice

Rao T.S.; Baker G.B.; Coutts R.T., 1987: Pharmacokinetic and neurochemical studies on n propargyl 2 phenylethylamine a prodrug of 2 phenylethylamine

Oosterhuis B.; Jonkman J.H.G.; Kerkhof F.A., 1988: Pharmacokinetic and pharmacodynamic comparison of a new controlled release formulation of metoprolol with a traditional slow release formulation

Traeger A.; Stein G.; Sperschneider H.; Keil E., 1984: Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function

Reimann I.W.; Jedrychowski M.; Schulz R.; Antonin K H.; Roth A.; Bieck P.R., 1987: Pharmacokinetic and pharmacodynamic effects of the novel benzodiazepine antagonist 2 phenylpyrazolo 4 3 c quinolin 3 5h one in humans

Marone C.; Muggli F.; Lahn W.; Frey F.J., 1985: Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man

Nakahama H.; Orita Y.; Yamazaki M.; Itoh S.; Okuda T.; Yamaji A.; Miwa Y.; Yanase M.; Fukuhara Y.; Kamada T., 1988: Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients

Prichett E.L.C.; Smith W.M.; Kirsten E.B., 1988: Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine

Aedo A R.; Landgren B M.; Johannisson E.; Diczfalusy E., 1985: Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations

Holazo A.A.; Brazzell R.K.; Colburn W.A., 1986: Pharmacokinetic and pharmacodynamic modeling of cibenzoline plasma concentrations and antiarrhythmic effect

Celardo A.; Traina G.L.; Arboix M.; Puigdemont A.; Bonati M., 1987: Pharmacokinetic and pharmacodynamic modelling of atenolol in rabbits maintained on continuous peritoneal dialysis

Meredith P.A.; Elliott H.L.; Kelman A.W.; Vincent J.; Reid J.L., 1988: Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin

Sandberg A.; Blomqvist I.; Jonsson U.E.; Lundborg P., 1988: Pharmacokinetic and pharmacodynamic properties of a new controlled release formulation of metoprolol a comparison with conventional tablets

Weber R.R.; Mccoy C.E.; Ziemniak J.A.; Frederickson E.D.; Goldberg L.I.; Murphy M.B., 1988: Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam a dopamine 1 receptor agonist in hypertensive patients

Grimaldi R.; Perucca E.; Ruberto G.; Gelmi C.; Trimarchi F.; Hollmann M.; Crema A., 1986: Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects

Saletu B.; Gruneberger J.; Cepko H., 1986: Pharmacokinetic and pharmacodynamic studies in elderlies with a potential antihypoxidotic nootropic drug tenilsetam utilizing pharmacoelectroencephalography and psychometry

Yacobi A.; Lai C M.; Levy G., 1984: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats

Tazaki T., 1988: Pharmacokinetic and pharmacodynamic studies of butoctamide hydrogen succinate bahs

Edgar B.; Regardh C.C.; Lundborg P.; Romare S.; Nyberg G.; Ronn O., 1987: Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single oral and intravenous doses

Lu, W.; Endoh, M.; Katayama, K.; Kakemi, M.; Koizumi, T., 1987: Pharmacokinetic and pharmacodynamic studies of piretanide in rabbits i. effect of different hydrated conditions

Lu, W.; Endoh, M.; Katayama, K.; Kakemi, M.; Koizumi, T., 1988: Pharmacokinetic and pharmacodynamic studies of piretanide in rabbits ii. effects on the proximal tubules and the loop of henle

Xiao B.; Zhang X.; Feng D., 1985: Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low dose levonorgestrel

Kholkute S.D.; Kumar T.C.A.; Puri C.P., 1987: Pharmacokinetic and pharmacodynamic studies on estradiol 17 beta administered sublingually or intramuscularly to adult male marmosets

Dencker S.J.; Johansson R.; Malm U., 1988: Pharmacokinetic and pharmacodynamic studies on high doses of fluphenazine

Hamilton C.A.; Reid J.L.; Vincent J., 1985: Pharmacokinetic and pharmacodynamic studies with two alpha adrenoceptor antagonists doxazosin and prazosin in the rabbit

Lu, W.; Endoh, M.; Katayama, K.; Kakemi, M.; Koizumi, T., 1988: Pharmacokinetic and pharmacodynamics studies of piretanide in rabbits iii. sodium and potassium excretion under different hydrated conditions

Tanaka H.; Naito S I., 1985: Pharmacokinetic and pharmacological studies on cetraxate an antiulcer agent

Kreis W.; Rottach C.; Budman D.R.; Chan K.; Schulman P.; Allen S.L.; Weiselberg L.; Vinciguerra V., 1988: Pharmacokinetic and phase i evaluation of esorubicin 4 deoxydoxorubicin by continuous infusion over forty eight hours in patients with leukemia

Sullivan M.P.; Nelson J.A.; Feldman S.; Van Nguyen B., 1988: Pharmacokinetic and phase i study in intravenous don 6 diazo 5 oxo l norleucine in children

Small R.E.; Johnson S.M.; Willis H.E., 1988: Pharmacokinetic and taste evaluation of ibuprofen motrin 800 mg tablets in extemporaneous solution

Jones S.; Yu V.L.; Johnson J.T.; Wagner R.L.; Kim H K.C., 1985: Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis

Forastiere, A. A.; Belliveau, J. F.; Goren, M. P.; Vogel, W. C.; Posner, M. R.; O'leary, G. P-Jr, 1988: Pharmacokinetic and toxicity evaluation of five day continuous infusion vs. intermittent bolus cis diamminedichloroplatinum ii in head and neck cancer patients

Van Peer A.; Woestenborghs R.; Embrechts L.; Heykants J., 1986: Pharmacokinetic approach to equilibrium between ketanserin and ketanserinol

Inaba M.; Kobayashi T.; Tashiro T.; Sakurai Y., 1988: Pharmacokinetic approach to rational therapeutic doses for human tumor bearing nude mice

Cheung W.K.; Yacobi A.; Silber B.M., 1988: Pharmacokinetic approach to the rational design of controlled or sustained release formulations

Myung H J.; Park C W.; Shin S G.; Lee K W., 1985: Pharmacokinetic approaches for the optimum phenytoin administration

Levin V.A.; Landahl H.D., 1985: Pharmacokinetic approaches to drug distribution in the cerebrospinal fluid based on ventricular administration in beagle dogs

Pfeifer G.; Frenkel C.; Entzian W., 1985: Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin

Lur'e A.A.; Shcherbakov A.M.; Lu Thi Van Tuu; Nguyen Thi Nu Mai; Le Duk Dao, 1986: Pharmacokinetic aspects of combining pyrimethamine and sulfanilamides

Lewandowski C.; Klug S.; Nau H.; Neubert D., 1986: Pharmacokinetic aspects of drug effects in vitro effects of serum protein binding on concentration and teratogenicity of valproic acid and 2 en valproic acid in whole embryos in culture

Gonzalez J.; Aza M.J.; Marino E.; Esteller A., 1987: Pharmacokinetic aspects of sulfobromophthalein transport after diethyl maleate pretreatment in rats

Magyar K., 1987: Pharmacokinetic aspects of the mode of action of egyt 475 a new antidepressant agent

Ito K.; IIda K.; Kondo H.; Noda K.; Hayasaki M.; Sumi H.; Kadomoto N., 1987: Pharmacokinetic bacteriological and clinical studies of czon in the field of obstetrics and gynecology

Obata I.; Tsuruoka N.; Koike K.; Morimoto O.; Arihiro T.; Hachiya S.; Yamato T.; Hayashi S.; Hayashi M., 1987: Pharmacokinetic bacteriological and clinical studies on cefuzonam in the field of obstetrics and gynecology

Shankaran S.; Cepeda E.E.; Ilagan N.; Kauffman R.E., 1986: Pharmacokinetic basis for antenatal dosing of phenobarbital for the prevention of neonatal intracerebral hemorrhage

Couet W.; Reigner B.G.; Fourtillan J.B., 1988: Pharmacokinetic basis of bioavailability determinations

Marino A.; Pisanti N., 1984: Pharmacokinetic basis of monitoring of antiepileptic drugs

Young J.F., 1984: Pharmacokinetic basis of pharmacodynamic predictions

Tamalet C.; Jadot G.; Valli M.; Payan M.J.; Bussiere H.; Bouyard P., 1986: Pharmacokinetic biochemical and histological study of the carbamazepine josamycin interaction after chronic administration in rats

Henderson J.D.; Olson R.D.; Ravis W.R., 1985: Pharmacokinetic calculator program for generation of initial parameter estimates from a 3 compartment infusion model

Soback S.; Ziv G.; Bogin E.; Cohen Z.; Earon Y., 1987: Pharmacokinetic changes of several antibiotics of chickens during induced fatty liver

Holland F.J.; Fishman L.; Costigan D.C.; Luna L.; Leeder S., 1986: Pharmacokinetic characteristics of the gonadotropin releasing hormone analog buserelin after subcutaneous and intranasal administration in children with central precocious puberty

Tukiainen H.; Silvasti M.; Karttunen P.; Savolainen K.; Kokkonen P.; Parviainen M., 1988: Pharmacokinetic comparison of a slow release theophylline hydroxyzine combination and a plain slow release theophylline preparation

Vermorken J.B.; Van Der Vijgh W.J.F.; Klein I.; Gall H.E.; Splinter T.A.W.; Hart A.A.M.; Pinedo H.M. , 1986: Pharmacokinetic comparison of cisplatin in solution with common lyophilized cisplatinum platinol

Citron M.L.; Reynolds J.R.; Kalra J.; Kay B.G.; Nathan K.A.; Jaffe N.D.; Miller F.R., 1987: Pharmacokinetic comparison of intranasal oral and intramuscular metoclopramide in healthy volunteers

Lim J K.; Park C W.; Shin S G.; Kim Y S., 1984: Pharmacokinetic comparison of oral bacampicillin and ampicillin

Galinsky R.E.; Nelson E.B.; Rollins D.E., 1987: Pharmacokinetic consequences and toxicologic implications of metyrapone induced alterations of acetaminophen elimination in man

Pourbaix S.; Desager J.P.; Hulhoven R.; Smith R.B.; Harvengt C., 1985: Pharmacokinetic consequences of long term coadministration of cimetidine and triazolobenzodiazepines alprazolam and triazolam in healthy subjects

Richter O.; Klatte A.; Abel J.; Freye E.; Haag W.; Hartung E., 1985: Pharmacokinetic data analysis of alfentanil after multiple injections and etomidate infusion in patients undergoing orthopedic surgery

Whalen C.E.; Soldin S.J.; Sulh H.; Koren G.; Greenberg M., 1986: Pharmacokinetic determinants of 6 mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia

Blumer J.L.; Rothstein F.C.; Kaplan B.S.; Yamashita T.S.; Eshelman F.N.; Myers C.M.; Reed M.D., 1985: Pharmacokinetic determination of ranitidine pharmacodynamics in pediatric ulcer disease

Talit U.; Braun S.; Halkin H.; Shargorodsky B.; Laniado S., 1985: Pharmacokinetic differences between peripheral and central drug administration during cardiopulmonary resuscitation

Hidiroglou M.; Karpinski K., 1988: Pharmacokinetic disposition in sheep of various vitamin e preparations given orally or intravenously

Pearson J.G.; Antal E.J.; Raehl C.L.; Gorsch H.K.; Craig W.A.; Albert K.S.; Welling P.G., 1986: Pharmacokinetic disposition of carbon 14 glyburide in patients with varying renal function

Blythe L.L.; Craig A.M.; Christensen J.M.; Appell L.H.; Slizeski M.L., 1986: Pharmacokinetic disposition of dmso administered intravenously to horses

Esquivel M.; Ogilvie R.I.; East D.S.; Shaw D.H.Jr; Heathcote J., 1987: Pharmacokinetic disposition of isoxicam in hepatic cirrhosis

Kochak G.M.; Rakhit A.; Honc F.; Mahoney C.J., 1988: Pharmacokinetic disposition of the novel atypical anxiolytic cgs 9896 in the cynomolgus monkey

Kimura T., 1987: Pharmacokinetic disposition of theophylline in hepatic disorders

Antman E.M.; Arnold J.M.O.; Friedman P.L.; Smith T.W., 1987: Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents an appraisal of study methodology

Muirhead M.; Bochner F.; Somogyi A., 1988: Pharmacokinetic drug interactions between triamterene and ranitidine in humans alterations in renal and hepatic clearances and gastrointestinal absorption

Keller F.; Maiga M.; Neumayer H H.; Lode H.; Distler A., 1984: Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease

Guerrini V.H.; English P.B.; Filippich L.J.; Schneider J.; Bourne D.W.A., 1986: Pharmacokinetic evaluation of a slow release cefotaxime suspension in the dog and in sheep

Michalsen H.; Bergan T.; Solberg R., 1986: Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases

Stile I.L.; Simon R.; Hiatt I.M.; Hegyi T., 1985: Pharmacokinetic evaluation of cimetidine in newborn infants

Kuemmerle H P.; Murakawa T.; De Santis F., 1987: Pharmacokinetic evaluation of fosfidomycin a new phosphonic acid antibiotic

Holthuis J.J.M.; Van De Vyer F.L.; Van Oort W.J.; Verleun H.; Bekaert A.B.; De Broe M.E., 1985: Pharmacokinetic evaluation of increasing dosages of etoposide in a chronic hemodialysis patient

Daemen M.J.A.P.; Vervoort Peters H.T.M.; Thijssen H.H.W., 1988: Pharmacokinetic evaluation of local drug delivery the intratesticular and intrarenal administration of acenocoumarol in the rat

Bialer M.; Friedman M.; Dubrovsky J.; Raz I.; Abramsky O., 1985: Pharmacokinetic evaluation of novel sustained release dosage forms of valproic acid in humans

Rafferty B.; Coy D.H.; Poole S., 1988: Pharmacokinetic evaluation of superactive analogues of growth hormone releasing factor 1 29 amide

Fenster P.E.; White N.W.Jr; Hanson C.D., 1985: Pharmacokinetic evaluation of the digoxin amiodarone interaction

Leucuta S.E.; Blaga S.; Vlaicu R., 1987: Pharmacokinetic evaluation of the pharmacodynamic effect of digoxin after the administration of a single internal dose to healthy volunteers

Wecker M.T.; Woodworth J.R.; Amsel L.P.; Hinsvark O.N.; Rotenberg K.S., 1986: Pharmacokinetic evaluation of two doxepin products

Humphrey M.J.; Jevons S.; Tarbit M.H., 1985: Pharmacokinetic evaluation of uk 49858 a metabolically stable triazole antifungal drug in animals and humans

Mitsuyama S.; Masumi A.; Katayama K.; Kakemi M.; Koizumi T., 1985: Pharmacokinetic evidence for blood flow depression in dose dependent disposition of 4 aminoantipyrine in rabbits

Prelusky, D. B.; Hartin, K. E.; Trenholm, H. L.; Miller, J. D., 1988: Pharmacokinetic fate of carbon 14 labeled deoxynivalenol in swine

Navasardyan A.A., 1984: Pharmacokinetic features of gentamicin in immunized rabbits

Silke B.; Graham D.J.M.; Verma S.P.; Reynolds G.; Frais M.A.; Finlayson J.R.; Taylor S.H., 1986: Pharmacokinetic hemodynamic and radionuclide studies with nicardipine in coronary artery disease

Blei A.T.; Friedman S.; Gottstein J.; Robertson G.; Fung H L., 1985: Pharmacokinetic hemodynamic interactions between vasopressin and nitroglycerin comparison between intravenous and cutaneous routes of nitrate delivery

Armstrong P.W., 1987: Pharmacokinetic hemodynamic studies of transdermal nitroglycerin in congestive heart failure

Knudsen P.; Hansen L.B.; Larsen N E., 1985: Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment

Somani P.; Fraker T.D.Jr; Temesy Armos P.N., 1987: Pharmacokinetic implications of lorcainide therapy in patients with normal and depressed cardiac function

Krishna D.R.; Rao A.V.N.A.; Ramanakar T.V.; Prabhakar M.C., 1986: Pharmacokinetic interaction between dapsone and rifampicin in leprosy patients

Zylber Katz E.; Turetz Abramovitch M.; Koren G.; Levy M., 1988: Pharmacokinetic interaction between nifedipine and propranolol

Busby M.; Lesko J.L., 1987: Pharmacokinetic interaction between theophylline and chloramphenicol in rats

Nitelius E.; Melander A.; Wahlin Boll E., 1985: Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole

Smith S.R.; Wilkins M.R.; Jack D.B.; Kendall M.J.; Laugher S., 1987: Pharmacokinetic interactions between felodipine and metoprolol

De Bruijn E.A.; Driessen O.; Leeflang P.; Van Den Bosch N.; Van Strijen E.; Slee P.H.T.J.; Hermans J., 1986: Pharmacokinetic interactions of cyclophosphamide and 5 fluorouracil with methotrexate in an animal model

Bianchetti G.; Padovani P.; Thenot J.P.; Thiercelin J.F.; Morselli P.L., 1987: Pharmacokinetic interactions of progabide with other antiepileptic drugs

Guggenbichler J.P.; Parth J.; Frisch H., 1986: Pharmacokinetic investigation of ceftriaxone in premature and newborn babies

Bradbrook I.D.; John V.A.; Morrison P.J.; Rogers H.J.; Spector R.G., 1985: Pharmacokinetic investigation of the absorption of oxprenolol from oros delivery systems in healthy volunteers comparison of in vivo and in vitro drug release

Rostock G.; Faulhaber H D.; Gohlke H R.; Prehm C., 1986: Pharmacokinetic investigations in steady state of relative bioavailability of two propranolol preparations in patients with essential hypertension

Capone D.; Del Rio A.; Campanella G.; De Marino V.; Pisanti N., 1988: Pharmacokinetic investigations on some antiepileptic drugs

Voigt R.; Patsch R.; Schroeder S.; Peiker G.; Brandstaedt A., 1985: Pharmacokinetic investigations using azlocillin during pregnancy

Lashev L., 1986: Pharmacokinetic investigations with birds

Dunne A., 1985: Pharmacokinetic lag time estimation

Wijnand H.P., 1988: Pharmacokinetic model equations for the one and two compartment models with first order processes in which the absorption and exponential elimination or distribution rate constants are equal

Karara A.H.; Hayton W.L., 1984: Pharmacokinetic model for the uptake and disposition of di 2 ethylhexyl phthalate in sheepshead minnow cyprinodon variegatus

Maislos M.; Bialer M.; Mead P.M.; Robbins D.C., 1988: Pharmacokinetic model of circulating covalent aggregates of insulin

Tojo K., 1988: Pharmacokinetic model of transcorneal drug delivery

Bornemann L.D.; Colburn W.A., 1985: Pharmacokinetic model to describe the disposition of lead in the rat

Yamamoto K.; Kohda Y.; Saitoh Y.; Nakagawa F., 1987: Pharmacokinetic modeling for dose dependent bioavailability of phenytoin powders

Dingemanse J.; Sollie F.A.E.; Breimer D.D.; Danhof M., 1988: Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazole threshold concentration as pharmacodynamic measure

Menzel D.B.; Deal D.L.; Tayyeb M.I.; Wolpert R.L.; Boger J.R.IIi; Shoaf C.R.; Sandy J.; Wilkinson K.; Francovitch R.J., 1987: Pharmacokinetic modeling of the lung burden from repeated inhalation of nickel aerosols

Lahteenmaki P.L.A.; Kurunmaki H.; Lahteenmaki P.; Toivonen J.; Luukkainen T., 1984: Pharmacokinetic observation on st 1435 administered subcutaneously and intravaginally

Bano G.; Raina R.K.; Sharma D.B., 1986: Pharmacokinetic of carbamazepine in protein energy malnutrition

Terao N.; Shen D.D., 1984: Pharmacokinetic of levo propranolol during repetitive dosing in normal and uranyl nitrate induced renal failure rats

Sheiner L.B.; Beal S.L., 1985: Pharmacokinetic parameter estimates from several least squares procedures superiority of extended least squares

Logvin P.A.; Golovkin V.A.; Slobodyanyuk T.A., 1987: Pharmacokinetic parameters and bioavailability of xanthiverine tablets

Vermeij P.; Van Brummelen P., 1986: Pharmacokinetic parameters of bevantolol in volunteers

Barrigon S.; Moreno A.; Rebollo D.; Garcia De Jalon P.D., 1986: Pharmacokinetic parameters of iodine 125 iodopropylidene glycerol in healthy volunteers

Torrecilla Junyent M.T.; Alos Alminana M.; Guevara Serrano J.; Garcia Mina Freire M.; Ezquer Borras J.; Magraner Gil J., 1987: Pharmacokinetic parameters of valproic acid clearance half life elimination constant

Braeunlich H.; Penzold K.; Tiersch W.; Fleck C.; Winnefeld K.; Stein G., 1988: Pharmacokinetic pattern and renal effects of aluminum in rats with impaired kidney or liver function

Eschalier, A.; Fialip, J.; Varoquaux, O.; Makambila, M. C.; Marty, H.; Bastide, P., 1988: Pharmacokinetic patterns of repeated administration of antidepressants in animals i. implications for antinociceptive action of clomipramine in mice

Huang S K.; Liu X D., 1987: Pharmacokinetic perfusion model of presystemic metabolism with renal clearance

Thibonnier M.; Holford N.H.G.; Upton R.A.; Blume C.D.; Williams R.L., 1984: Pharmacokinetic pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man

Graziani G.; Abbiati G.A.; Dolfini E.; Testa R.; Velo G.P., 1987: Pharmacokinetic pharmacodynamic and toxicological properties of naproxen gel in laboratory animals

Koopmans R.; Dingemanse J.; Danhof M.; Horsten G.P.M.; Van Boxtel C.J., 1988: Pharmacokinetic pharmacodynamic modeling of midazolam effects on the human central nervous system

Oosterhuis B.; Braat M.C.P.; Roos C.M.; Wemer J.; Van Boxtel C.J., 1986: Pharmacokinetic pharmacodynamic modeling of terbutaline bronchodilation in asthma

Koopmans R.; Oosterhuis B.; Karemaker J.M.; Wemer J.; Van Boxtel C.J., 1988: Pharmacokinetic pharmacodynamic modelling of oxyprenolol in man using continuous non invasive blood pressure monitoring

Sjostrom P.; Beermann B.; Odlind B., 1987: Pharmacokinetic pharmacodynamic relationship of piretanide in healthy and uremic subjects determinants of the diuretic effect of a loop diuretic

Kuemmerle H P.; Hitzenberger G.; Nieder G.; Rasper J.; Jaeger H., 1984: Pharmacokinetic pilot study with imidazole 2 hydroxybenzoate using new analytical methods

Mooradian A.D.; Wynn E.M., 1987: Pharmacokinetic prediction of serum digoxin concentration in the elderly

Koryakin V.A.; Sokolova G.B.; Ziya A.V.; Zeliger L.R.; Ivleva A.Ya; Nikolaev V.P., 1987: Pharmacokinetic principles of drugless prevention of drug hepatitides in patients with pulmonary tuberculosis

Chen R.; Gillette J.R., 1988: Pharmacokinetic procedures for the estimation of organ clearances for the formation of short lived metabolites acetaminophen induced glutathione depletion in hamster liver

Bonfanti M.; Magagnotti C.; Bonati M.; Fanelli R.; Airoldi L., 1988: Pharmacokinetic profile and metabolism of n nitrosobutyl 4 hydroxybutylamine in rats

Sharma B.; Mehta S.; Nain C.K.; Mathur V.S., 1985: Pharmacokinetic profile of antipyrine in young rhesus monkeys macaca mulatta with protein energy malnutrition

Dennis M.J.; French P.C.; Crome P.; Babiker M.; Shillingford J.; Hopkins R., 1985: Pharmacokinetic profile of controlled release ketoprofen in elderly patients

Faraci M.; Vigeant C.; Yale J F., 1988: Pharmacokinetic profile of cyclosporine a and g and their effects on cellular immunity and glucose tolerance in male and female wistar rats

Kuemmerle H P.; Dominguez Gil A.; Koepcke K.; Hitzenberger G., 1986: Pharmacokinetic profile of imidazole 2 hydroxybenzoate a novel nonsteroidal antiinflammatory agent

Lund B.; Egsmose C.; Knudsen O.; Andersen R.B., 1986: Pharmacokinetic profile of indoprofen in elderly subjects

Gielsdorf W.; Molz K H.; Hausleiter H.J.; Achtert G.; Philipp P., 1986: Pharmacokinetic profile of metaclazepam talis a new 1 4 benzodiazepine influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady state conditions

Ohnishi A.; Ishizaki T., 1988: Pharmacokinetic profile of opc 8212 in humans a new nonglycosidic inotropic agent

Yonemitsu K., 1986: Pharmacokinetic profile of paraquat following intravenous administration to the rabbit

Othman M.A.; Abou Donia M.B., 1988: Pharmacokinetic profile of racemic gossypol in male sprague dawley rats following single intravenous and oral and subchronic oral administration

Morita Y.; Iwaya N.; Shinkuma D.; Miyoshi K., 1987: Pharmacokinetic profiles and temporal changes in quantitative eeg after imipramine administrations

Campbell A.J.; Ferry D.G.; Edwards I.R., 1985: Pharmacokinetic projections for isoxicam and piroxicam in old and young subjects

Jansson R.; Lindstrom B.; Dahlberg P.A., 1985: Pharmacokinetic properties and bioavailability of methimazole

Onoyama K.; Kumagai H.; Nanishi F.; Okuda S.; Hirakata H.; Omae T.; Hayashi K.; Fujishima M., 1986: Pharmacokinetic properties of a new angiotensin i converting enzyme inhibitor alacepril in normal office workers

Bergogne Berezin E., 1984: Pharmacokinetic properties of ceftazidime

Onoyama K.; Oochi N.; Ando T.; Fujishima M.; Uji Y.; Kobayashi S., 1988: Pharmacokinetic properties of ketanserin in patients with chronic renal failure after single dose oral administration

Meyers B.R.; Mendelson M.H.; Srulevitch Chin E.; Bradbury K.; Mcmurdo L.; Hirschman S.Z., 1987: Pharmacokinetic properties of mezlocillin in ambulatory elderly subjects

Fujioka M.; Shinohara Y.; Baba S.; Irie M.; Inoue K., 1986: Pharmacokinetic properties of testosterone propionate in normal men

Kawai S.; Nieman L.K.; Brandon D.D.; Udelsman R.; Loriaux D.L.; Chrousos G.P., 1987: Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid ru 486 in man

Feodorov V.; Chaleva E.; Kazachka D.; Naneva G., 1987: Pharmacokinetic research and ultrastructural changes of the lungs of albino rats after aerosol application of high doses of kanamycin sulfate

Nouws J.F.M.; Vree T.B.; Holtkamp J.; Baakman M.; Driessens F.; Guelen P.J.M., 1988: Pharmacokinetic residue and irritation aspects of chloramphenicol sodium succinate and a chloramphenicol base formulation following intramuscular administration to ruminants

Moreno V.; Farre M.; Salva P., 1986: Pharmacokinetic simulation with computers teaching application

Piotrovskii V.K., 1987: Pharmacokinetic stochastic model with weibull distributed residence times of drug molecules in the body

Lorenz D.; Luecker P.W.; Krumbiegel G.; Mennicke W.H.; Wetzelsberger N., 1985: Pharmacokinetic studies in alizarin in man

Shimada J.; Saito A.; Shiba K.; Yamaji T.; Hojo T.; Kaji M.; Hori S.; Okuda S.; Miyahara T., 1986: Pharmacokinetic studies of a new oral cephem t 2588 pharmacokinetics in gastrectomized volunteers and renal excretion system in healthy volunteers

Yamasaku F.; Kobayashi S.; Inoue A., 1986: Pharmacokinetic studies of astromicin using a constant rate continuous intravenous infusion method

Voigt R.; Schroeder S.; Peiker G., 1985: Pharmacokinetic studies of azlocillin and piperacillin during late pregnancy

Klebovich I.; Csetenyi J.; Kerpel Fronius S.; Vereczkey L., 1987: Pharmacokinetic studies of carbon 14 flumecinol in humans

Seiga K.; Sugiyama Y., 1984: Pharmacokinetic studies of cefbuperazone in the field of gynecology

Arvidsson A.; Alvan G.; Tranaeus A.; Malmborg A.S., 1985: Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis

Yamasaki H.; Arima T.; Nagashima H., 1987: Pharmacokinetic studies of cimetidine in patients with liver disease

Prokopenko V.D.; Tyulyandin S.A.; Bud'ko A.P.; Shevcheno V.E., 1984: Pharmacokinetic studies of cyclophosphane in hemosorption in lung cancer patients

Wiemeyer J.C.M.; Hernandez M.; Sagasta C.L.; Moguilevsky J.A., 1987: Pharmacokinetic studies of estradiol enantate in menopausal women

Wiemeyer J.C.M.; Fernandez M.; Moguilevsky J.A.; Sagasta C.L., 1986: Pharmacokinetic studies of estradiol enantate in menopausic women

Molitch M.E.; Raiti S.; Baumann G.; Belknap S.; Reichlin S., 1987: Pharmacokinetic studies of highly purified human prolactin in normal human subjects

Takashima Y.; Matsuyama K., 1987: Pharmacokinetic studies of intermediate to high dose 1 beta d arabinofuranosylcytosine in children with acute leukemia and lymphoma

Lo P K.A.; Fink D.W.; Williams J.B.; Blodinger J., 1985: Pharmacokinetic studies of ivermectin effects of formulation

Koren G.; Zylber Katz E.; Granit L.; Levy M., 1986: Pharmacokinetic studies of nifedipine and digoxin co administration

Gilfillan E.C.; Pelak B.A.; Bland J.A.; Malatesta P.F.; Gadebusch H.H., 1984: Pharmacokinetic studies of norfloxacin in laboratory animals

Wang L.H.; Rudolph A.M.; Benet L.Z., 1986: Pharmacokinetic studies of the disposition of acetaminophen in the sheep maternal placental fetal unit

Yumita N.; Nishigaki R.; Umemura K.; Hayashi T.; Kigasawa K., 1985: Pharmacokinetic studies of the inhibition of glucuronization of pentazocine by salicylamide

Hayashida, K.; Akaike, Y.; Nakamura, S.; Miura, Y.; Arai, Y.; Ono, Y.; Takeyama, S., 1987: Pharmacokinetic studies on 1 2 chloroethyl 3 isobutyl 3 beta maltosyl 1 nitrosourea ta 077 i. blood and tissue concentrations of a new nitrosourea antitumor agent ta 077 and its metabolite ta g after intravenous injection of ta 077 in various experimental animals

Hayashida, K.; Oda, K.; Akaike, Y.; Arai, Y.; Takeyama, S., 1987: Pharmacokinetic studies on 1 2 chloroethyl 3 isobutyl 3 beta maltosyl 1 nitrosourea ta 077 ii. hydrolysis by tissue homogenates and drug uptake by tumor cells in vitro

Hayashida, K.; Miura, Y.; Arai, Y.; Takeyama, S.; Wakui, A.; Yokoyama, M.; Kanamaru, R.; Majima, H.; Taguchi, T.; Et-Al, 1987: Pharmacokinetic studies on 1 2 chloroethyl 3 isobutyl 3 beta maltosyl 1 nitrosourea ta 077 iii. pharmacokinetics of a new nitrosourea antitumor agent ta 077 in humans a phase i study

Zhao B.; Zhao X L., 1988: Pharmacokinetic studies on 5 fluorouracil and its metabolite in rabbits by high pressure liquid chromatography

Acocella, G.; Conti, R.; Luisetti, M.; Pozzi, E.; Grassi, C., 1985: Pharmacokinetic studies on antituberculosis regimens in humans 1. absorption and metabolism of the compounds used in the initial intensive phase of the short course regimens single administration study

Kobayashi S.; Inoue A.; Deguchi T., 1986: Pharmacokinetic studies on astromicin in dogs intramuscular intravenous or drip intravenous administration

Fujimoto S.; Akahane M.; Hagisawa M.; Nakajima T.; Hattori T.; Sato H.; Sugawara T.; Takeda K.; Ichinoe K.; Ishiguro N., 1986: Pharmacokinetic studies on aztreonam in the late pregnancy of sheep and human

Shindo K.; Tsuburaya T.; Atsumi Y.; Sato M., 1986: Pharmacokinetic studies on cefmenoxime distributions into uterus and intrapelvic genital organs

Nishimura T.; Tabuki K.; Takashima T., 1986: Pharmacokinetic studies on ceftazidime in neonates

Fraschini F.; Scaglione F.; De Pascale A.; Del Mastro S., 1986: Pharmacokinetic studies on ceftezole

Koeppe P.; Hoeffler D.; Hulla F.W., 1987: Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency

Endoh M.; Suzuki M.; Kuroda T.; Katayama K.; Kakemi M.; Koizumi T., 1985: Pharmacokinetic studies on pharmacologic response of captopril in rats

Hayashi T.; Watanabe Y.; Kumano K.; Kitayama R.; Yasuda T.; Saikawa I.; Totsuka K.; Kumada T.; Shimizu K., 1986: Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin and piperacillin and cefoperazone in rabbits

Wang J X.; Zhao S Q.; Lin B H.; Wang L G.; Yi M G., 1985: Pharmacokinetic studies on tritiated aclacinomycin b in mice

Jain S.K.; Vyas S.P., 1987: Pharmacokinetic studies on warfarin sodium after antibiotic therapy using drug urinary excretion data

Landgren B.M.; Aedo A.R.; Cekan S.Z.; Diczfalusy E., 1986: Pharmacokinetic studies with a vaginal delivery system releasing levonorgestrel at a near zero order rate for one year

Santos R.M.; Pierangelo S.; Martins R.; Morais R.; Silva A.J.R.D.; Seabra A.P.; Lima D.R.A., 1988: Pharmacokinetic studies with ketoprofen in the brazilian population

Reddi E.; Lo Castro G.; Biolo R.; Jori G., 1987: Pharmacokinetic studies with zinc ii phthalocyanine tumor bearing mice

Veyssier P.; Montagne V.; Darchis J.P.; Kaloustian E.; Lokiec F., 1987: Pharmacokinetic study after intravenous administration of ceftriaxone in elderly

Fujii M.; Inuyama Y.; Tanaka J.; Takaoka T.; Hosoda H., 1986: Pharmacokinetic study for combination therapy of cisplatin and peplomycin

Bareggi S.R.; Pedrazzini S.; De Angelis M., 1988: Pharmacokinetic study in man with the non steroidal antiinflammatory drug flunoxaprofen serum concentration time profile after oral or topical preparations

Saux M.C.; Fourtillan J.B.; Lefebvre M.A.; Mosser J.; Fontagnier H., 1984: Pharmacokinetic study of 2 aminophylline formulations during oral multiple dosing in smokers and nonsmokers

Giudicelli C P.; Ricordel I.; Nedelec G.; Didelot F.; Renaudeau C.; Schmit J M., 1987: Pharmacokinetic study of 2 dehydroemetine in the hemodialyzed chronic renal insufficiency patient

Suzuki H.; Sawada Y.; Sugiyama Y.; Iga T.; Hanano M., 1987: Pharmacokinetic study of 4 methylumbelliferone in mice

Morita K.; Sugiyama Y.; Hanano M., 1986: Pharmacokinetic study of 4 methylumbelliferone in rats influence of dose on its first pass hepatic elimination

Dumas J.; Goutalier J.; Quillon J P.; Rapin A.; Legoy M., 1986: Pharmacokinetic study of a chloramphenicol chlortetracycline association in the young calf

Bannai, H.; Tatsumi, M.; Kohase, M.; Onishi, E.; Tamazaki, S., 1985: Pharmacokinetic study of a human recombinant interferon in cynomolgus monkeys by 2' 5' oligoadenylate synthetase assay

Van Niekerk C.H.; Van Den Ende J.; Hundt H.K.L.; Louw E.A., 1985: Pharmacokinetic study of a pediatric formulation of amoxycillin and clavulanic acid in children

Geodakyan S.V.; Frisov A.A.; Fomina I.P., 1987: Pharmacokinetic study of aclarubicin blood pharmacokinetics of the drug and its biologically active metabolites in rats

Firsov A.A.; Geodakyan S.V.; Egorov L.V.; Terent'eva T.G., 1987: Pharmacokinetic study of aclarubicin distribution of the drug and its biologically active metabolites in the tissues of rats

Frutos G.; Cadorniga R.; Bellido V.; Llorente L.; Martin P., 1982: Pharmacokinetic study of adriamycin in dogs and rabbits in absence of carrier

Sumi M.; Watari N.; Umezawa O.; Kaneniwa N., 1987: Pharmacokinetic study of carbamazepine and its epoxide metabolite in humans

Washida H.; Tsugaya M.; Hirao N.; Sakagami H.; Iwase Y., 1985: Pharmacokinetic study of cefmenoxime concerning its transfer into tissues

Nin W W.; Lui Y H.; Wang Q N.; Qiu Z D.; Jiang Y F., 1985: Pharmacokinetic study of cefotaxime

Ikeda Y.; Higashijima T.; Oguchi Y.; Okumura K.; Ozeki M.; Okada A., 1985: Pharmacokinetic study of cefsulodin in children

Leigh D.A.; Griggs J.; Tighe C.M.; Powell H.D.W.; Church J.C.T.; Wise K.; Channon G.; Curtis L.B., 1985: Pharmacokinetic study of ceftazidime in bone and serum of patients undergoing hip and knee arthroplasty

Watson N.; Black W.D., 1986: Pharmacokinetic study of chloramphenicol in calves using sensitive gas liquid chromatographic analysis

Chen S.; Hei Y.; Zhou L.; Chen S.; Yan B.; Yang J.; Guo J., 1988: Pharmacokinetic study of chromium preparation in rabbits by compartment and non compartment analysis

Lize J.M.; Durand J.L.; Jungers P.; Divine C.; Bohbot M.; Fredj G.; Thuillier A., 1987: Pharmacokinetic study of cicletanine hydrochloride in renal failure

Tomono Y.; Hasegawa J.; Seki T.; Motegi K.; Morishita N., 1986: Pharmacokinetic study of deuterium labeled coenzyme q 10 in man

Kulakov V.N.; Pimenova G.N.; Kivman G.Ya; Shvarts I.Sh; Vasil'ev A.E., 1988: Pharmacokinetic study of dextran conjugates with catecholamines possessing hypotensive activity

Kulakov V.N.; Pimenova G.N.; Matveev V.A.; Sedov V.V.; Vasil'ev A.E., 1985: Pharmacokinetic study of drug polymers models on the basis of dextran

Baba T.; Matsukane I.; Kano T.; Morioka T., 1987: Pharmacokinetic study of epidural mepivacaine for cesarean section

Cadorniga R.; Barcia E.; Molina I.T.; Galiano A.; Gutierrez J.A., 1987: Pharmacokinetic study of guanyl cysteine

Bourin M.; Laporte V.; Guenzet J.; Langlois S.; Pengloan J.; Rouleau P., 1986: Pharmacokinetic study of ioxaglate a low osmolality contrast medium in patients with renal failure

Eksborg S.; Strandler H S.; Edsmyr F.; Naslund I.; Tahvanainen P., 1985: Pharmacokinetic study of iv infusions of adriamycin

Saito A.; Nakashima M., 1986: Pharmacokinetic study of lenampicillin kbt 1585 in healthy volunteers

Shi Y E.; Zheng S H.; Zhu Y H.; He C H.; Yu P P.; Fotherby K., 1988: Pharmacokinetic study of levonorgestrel used as a postcoital agent

Pimenova G.N.; Matveev V.A.; Kulakov V.N., 1986: Pharmacokinetic study of medicinal polymers radioisotope methods of pharmacokinetic studies

Rettenmaier M.A.; Miller R.D.; Berman M.L.; Disaia P.J., 1984: Pharmacokinetic study of moxalactam in patients undergoing gynecologic operations

Cantaluppi A.; Graziani G.; Ponticelli C.; Grasso S.; Meinardi G.; Piaia F.; Tamassia V., 1984: Pharmacokinetic study of new sulfamethopyrazine trimethoprim combination kelfiprim in renal insufficiency

Gutterman J.U.; Rosenblum M.G.; Rios A.; Fritsche H.A.; Quesada J.R., 1984: Pharmacokinetic study of partially pure gamma interferon in cancer patients

Nakata Y.; Fujita H.; Fujimoto J.; Okada H.; Obata T., 1987: Pharmacokinetic study of peplomycin given by continuous infusion from the vagina or cervix in squamous cell carcinoma of the uterine cervix

Ashraf A.Q.; Liau M.C.; Kampalath B.N.; Burzynski S.R., 1987: Pharmacokinetic study of radioactive antineoplaston a10 following oral administration in rats

Douillard J Y.; Chatal J F.; Saccavini J.C.; Curtet C.; Kremer M.; Peuvrel P.; Koprowski H., 1985: Pharmacokinetic study of radiolabeled anti colorectal carcinoma monoclonal antibodies in tumor bearing nude mice

Shim C K.; Kim D D.; Kim H S.; Jung I W.; Yoo M Y., 1987: Pharmacokinetic study of recombinant human interferon alpha a in rats

Trotta F.; Dovigo L.; Pellegrini P.; Tonon G.C.; Borsa M., 1984: Pharmacokinetic study of slow release ketoprofen lysine in patients with rheumatoid arthritis and osteoarthritis

Luna Perez B.A.; Fuentes Hernandez V.O.; Sumano Lopez H., 1988: Pharmacokinetic study of sodium sulfadimethylpyrimidine in goats to evaluate its action on mastitis

Murasaki M.; Yamazumi S.; Miura S.; Okamoto K.; Takashi A., 1984: Pharmacokinetic study of sultopride

Watari N.; Hanawa M.; Iwai M.; Kaneniwa N., 1984: Pharmacokinetic study of the enterohepatic circulation of acetaminophen glucuronide in rats

Cadorniga R.; Negro S.; Molina I.; Gutierrez J.A., 1987: Pharmacokinetic study of trihydrated pipemidic acid following intravenous infusion

Lartigue Mattei C.; Godeneche D.; Chabard J.L.; Petit J.; Berger J.A., 1984: Pharmacokinetic study of tritium labeled paf acether platelet activating factor 2 comparison with tritium labeled lyso paf acether after intravenous administration in the rabbit and protein binding

Cadorniga R.; Saiz Vadillo M.C.; Molina I.T.; Cadorniga L., 1984: Pharmacokinetic study of vincamine teprosilate

Rossi, C.; Zucchetti, M.; Sessa, C.; Urso, R.; Mangioni, C.; D'incalci, M., 1984: Pharmacokinetic study of vm 26 4' demethylepipodephyllotoxin 9 4 6 o 2 thenylidene beta d glucopyranoside given as a prolonged intravenous infusion to ovarian cancer patients

Fujii K.; Morio M.; Kikuchi H.; Mukaida K.; Sato N.; Yuge O.; Kawahara M., 1987: Pharmacokinetic study on excretion of inorganic fluoride ion a metabolite of sevoflurane

Acerbi D.; Bonati C.; Boscarino G.; Bufalino L.; Cesari F.; D'ambrosio E.; Mansanti P.; Scali G., 1988: Pharmacokinetic study on piroxicam at the steady state in elderly subjects and younger adults after administration of piroxicam beta cyclodextrin

Kawasaki S.; Sugiyama Y.; Iga T.; Hanano M.; Sanjo K.; Beppu T.; Idezuki Y., 1985: Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients

Yurino M., 1984: Pharmacokinetic study on the lidocaine concentration in serum during epidural anesthesia

Tearasaki T.; Iga T.; Sugiyama Y.; Hanano M., 1984: Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin interorgan and interspecies variation of tissue to plasma partition coefficients in rats rabbits and guinea pigs

Korsunskii V.N.; Tarasenko Yu I.; Koval'chuk N.D.; Kosheleva I.Yu; Popov V.I., 1986: Pharmacokinetic substantiation of using indium 111 labeled citrin to study the bone marrow

Siegel, R. A., 1986: Pharmacokinetic transfer functions and generalized clearances

Iwai N.; Miyazu M.; Nakamura H.; Katayama M.; Kasai K.; Taneda Y., 1987: Pharmacokinetical bacteriological and clinical studies of flomoxef in the pediatric field

Puigdellivol E.; Carral M.E.; Moreno J.; Pla Delfina J.M.; Jane F., 1985: Pharmacokinetics and absolute bioavailability of intramuscular tranexamic acid in man

Goldstein D.A.; Tan Y.K.; Soldin S.J., 1987: Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers

Shionoiri H.; Yasuda G.; Abe Y.; Yoshimura H.; Kaneko Y.; Shindo Y., 1987: Pharmacokinetics and acute effect on the renin angiotensin system of delapril in patients with chronic renal failure

Koren G.; Lau A.; Klein J.; Golas C.; Bologa Campeanu M.; Soldin S.; Macleod S.M.; Prober C., 1988: Pharmacokinetics and adverse effects of amphotericin b in infants and children

Vater M.; Smith G.; Aherne G.W.; Aitkenhead A.R., 1984: Pharmacokinetics and analgesic effect of slow release oral morphine sulfate in volunteers

Delatour P.; Besse S.; Romdane M.N., 1988: Pharmacokinetics and anti dicrocoelium effect of thiophanate and its major metabolite in ruminants

Double J.A.; Bibby M.C.; Loadman P.M., 1986: Pharmacokinetics and anti tumor activity of lm 985 in mice bearing transplantable adenocarcinomas of the colon

Hashimoto Y.; Hori R.; Okumura K.; Yasuhara M., 1986: Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion

Markwardt F.; Nowak G.; Stuerzebecher J.; Griessbach U.; Walsmann P.; Vogel G., 1984: Pharmacokinetics and anticoagulant effect of hirudin in man

Wills R.J.; Gallo Torres H.E.; Bertko R.; Min B.H., 1987: Pharmacokinetics and antisecretory activity of trimoprostil in heidenhain pouch dogs

Janicke D.M.; Cafarell R.F.; Parker S.W.; Apicella M.A.; Jusko W.J., 1985: Pharmacokinetics and aztreonam in patients with gram negative infections

Ginsburg C.M.; Mccracken G.H.Jr; Petruska M.; Olson K., 1985: Pharmacokinetics and bactericidal activity of cefuroxime axetil

Ginsburg C.M.; Mccracken G.H.Jr; Olsen K.; Petruska M., 1985: Pharmacokinetics and bactericidal activity of sultamicillin in infants and children

Syrogiannopoulos G.A.; Al Sabbagh A.; Olsen K.D.; Mccracken G.H.Jr, 1987: Pharmacokinetics and bacteriological efficacy of ticarcillin clavulanic acid timentin in experimental escherichia coli k 1 and haemophilus influenzae type b meningitis

Mcgourty J.C.; Silas J.H.; Fleming J.J.; Mcburney A.; Ward J.W., 1985: Pharmacokinetics and beta blocking effects of timolol in poor and extensive metabolizers of debrisoquine

Bowmer C.J.; Yates M.S., 1984: Pharmacokinetics and biliary excretion of bromosulfophthalein tritium labeled ouabain and tritium labeled taurocholic acid in rats with glycerol induced acute renal failure

Silberstein D.J.; Bowmer C.J.; Yates M.S., 1987: Pharmacokinetics and biliary excretion of rose bengal in rats with acute and chronic renal failure

Arancibia A.; Gonzalez G.; Icarte A.; Arancibia M.; Arancibia P., 1987: Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation

Vergin H.; Nuss U.; Strobel K., 1986: Pharmacokinetics and bioavailability of bendroflumethiazide in combination with spironolactone

V.Moellendorff E.; Reiff K.; Neugebauer G., 1987: Pharmacokinetics and bioavailability of carvedilol a vasodilating beta blocker

Locniskar A.; Lasseter K.C.; Freeland G.R.; Chiang S.T.; Greenblatt D.J., 1985: Pharmacokinetics and bioavailability of ciramadol a new analgesic

Macfarland R.T.; Marcus F.I.; Fenster P.E.; Graves P.E.; Perrier D., 1984: Pharmacokinetics and bioavailability of digitoxin by a specific assay

Kramer W.G.; Nagabhushan N.; Affimre M.B.; Perentesis G.P.; Symchowicz S.; Patrick J.E., 1988: Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers

Gielsdorf W.; Pabst G.; Lutz D.; Graf F., 1986: Pharmacokinetics and bioavailability of diphenhydramine in man

Capistron G.; Coulais Y.; Caillard C.; Mosser J.; Pontagnier H.; Houin G., 1986: Pharmacokinetics and bioavailability of doxycycline in humans

Schran H.F.; Mcdonald S.; Lehr R., 1988: Pharmacokinetics and bioavailability of ergoloid mesylates

Huang S M.; Abrams L.S.; Marriott T.B.; Weintraub H.S., 1988: Pharmacokinetics and bioavailability of etintidine in beagle dogs effects of routes of administration doses dosage forms and chronic dosing

Atef M.; El Sayed M.G.A.; Ramadan A., 1986: Pharmacokinetics and bioavailability of gentamicin in goats

Bareggi S.R.; Truci G.; Leva S.; Zecca L.; Pirola R.; Smirne S., 1988: Pharmacokinetics and bioavailability of intravenous and oral chlordemethyldiazepam in humans

Rameis H.; Bacher S.; Eichler H G.; Horwatitsch H., 1985: Pharmacokinetics and bioavailability of isosorbide 5 mononitrate in humans

Wagner T.; Drings P., 1986: Pharmacokinetics and bioavailability of oral ifosfamide

Laher M.S.; Hickey M.P., 1985: Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers

Trenk D.; Wagner F.; Jaehnchen E.; Spahn H.; Mutschler E., 1987: Pharmacokinetics and bioavailability of piretanide in healthy volunteers following intramuscular administration

Miller R., 1984: Pharmacokinetics and bioavailability of ranitidine in humans

Morichau Beauchant M.; Houin G.; Mavier P.; Alexandre C.; Dhumeaux D., 1986: Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients

Olsson B.; Johansson M.; Gabrielsson J.; Bolme P., 1988: Pharmacokinetics and bioavailability of reduced and oxidized n acetylcysteine

Blasco F.; Martinez J.M.; Von Schilling B.; Piulats J., 1986: Pharmacokinetics and bioavailability of reproterol after intratracheal administration in the rat

Brodie R.R.; Chasseaud L.F.; Darragh A.; Lambe R.F.; Rooney L.; Taylor T., 1986: Pharmacokinetics and bioavailability of the anti emetic agent bromopride

Pabst G.; Lutz D.; Molz K.H.; Dahmen W.; Jaeger H., 1986: Pharmacokinetics and bioavailability of three different galenic nifedipine preparations

Fourtillan J.B.; Bouquet S.; Girault J.; Lefebvre M.A.; Maulet C.; Courtois P., 1985: Pharmacokinetics and bioavailability of viqualine a new antidepressant

Srivastava A.K.; Malik J.K., 1986: Pharmacokinetics and biochemical effects of diacetyl monoxime in bubalus bubalis

Vergin H.; Mascher H.; Strobel K.; Nitsche V., 1986: Pharmacokinetics and bioequivalence of different formulations of pirenzepine

Gikalov I.; Ifflaender U., 1987: Pharmacokinetics and bioequivalence of two peroral beclobrate preparations

Schulz B.; Menzel R.; Ratsmann K.P.; Heinke P., 1987: Pharmacokinetics and biological activity of the new intermediate acting insulin l snc

Duesterberg B.; Schmidt Gollwitzer M.; Huempel M., 1985: Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women

Landahl S.; Edgar B.; Gabrielsson M.; Larsson M.; Lernfelt B.; Lundborg P.; Regardh C.G., 1988: Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients a comparison with young healthy subjects

Blumer J.L.; Aronoff S.C.; Myers C.M.; O'brien C.A.; Klinger J.D.; Reed M.D., 1985: Pharmacokinetics and cerebrospinal fluid penetration of ceftazidime in children with meningitis

Dhananjaya K.V.R.; Antony A., 1988: Pharmacokinetics and chemotherapeutic efficacy of adriamycin encapsulated in immunoliposomes against avian myeloblastosis virus infection

Ciraulo D.A.; Barnhill J.G.; Boxenbaum H.G.; Greenblatt D.J.; Smith R.B., 1986: Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder

Fujii R.; Meguro H.; Kim B.; Yonezawa H.; Kawaoi T.; Tajima T.; Mashiko J.; Nakazawa S.; Niino K.; Et Al, 1987: Pharmacokinetics and clinical effects of aspoxicillin in pediatric patients

Motohiro T.; Tanaka K.; Koga T.; Shimada Y.; Tomita S.; Nishiyama T.; Ishimoto K.; Tominaga K.; Yamashita F.; Et Al, 1986: Pharmacokinetics and clinical effects of cefixime in pediatrics

Ouslander J.G.; Blaustein J.; Connor A.; Orzeck S.; Yong C L., 1988: Pharmacokinetics and clinical effects of oxybutynin in geriatric patients

Pihlajamaki K.K.; Kanto J.H.; Oksman Caldentey K M., 1986: Pharmacokinetics and clinical effects of scopolamine in cesarean section patients

Regazzi M.B.; Rondanelli R.; Vidale E.; Chirico G.; Rondini G.; Chiara A.; Piccolo A., 1984: Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus

Gaudreault P.; Guay J.; Nicol O.; Dupuis C., 1988: Pharmacokinetics and clinical efficacy of intrarectal solution of acetaminophen

Ido M.; Ihara T.; Kamiya H.; Sakurai M., 1985: Pharmacokinetics and clinical evaluation of aztreonam in pediatrics

Kawamura S.; Sugita R.; Fujimaki Y.; Tanaka M.; Uchida T.; Deguchi K., 1985: Pharmacokinetics and clinical evaluation of cefoperazone in chronic suppurative otitis media

Yura J.; Tsuruga N.; Hashimoto T.; Kamiya Y.; Hayashi S.; Murata Y., 1986: Pharmacokinetics and clinical evaluation on cefotiam in pediatric surgery

Yura J.; Kamiya Y.; Tsuruga N.; Narita H.; Suzuki T., 1988: Pharmacokinetics and clinical evaluation on ceftriaxone in pediatric surgery

Fanta C.H.; Mcfadden E.R.Jr, 1985: Pharmacokinetics and clinical response to single and multiple dose sustained release theophylline compounds in perennial bronchial asthma

Motohiro T.; Oda K.; Aramaki M.; Kawakami A.; Tanaka K.; Koga T.; Shimada Y.; Tomita S.; Sakata Y.; Et Al, 1987: Pharmacokinetics and clinical studies of flomoxef in the pediatric field

Bando T.; Toyoshima H., 1984: Pharmacokinetics and clinical studies of fosfomycin in bile duct infections

Cho N.; Mitsukawa M.; Aoki K.; Kunii K.; Togo M.; Tamura T.; Fukunaga K., 1985: Pharmacokinetics and clinical studies on cefminox in obstetrics and gynecology

Cho N.; Fukunaga K.; Kunii K., 1985: Pharmacokinetics and clinical studies on cefpimizole in obstetrics and gynecology

Cho N.; Watanabe H.; Yoshida K.; Moriyama S.; Takeda H.; Tsukamoto A.; Fukunaga K.; Kunii K.; Komoriyama Y., 1984: Pharmacokinetics and clinical studies on ceftriaxone in the field of obstetrics and gynecology

Bateman D.N.; Blain P.G.; Woodhouse K.W.; Rawlins M.D.; Dyson H.; Heyworth R.; Prescott L.F.; Proudfoot A.T., 1985: Pharmacokinetics and clinical toxicity of quinine overdosage lack of efficacy of techniques intended to enhance elimination

Riviere, J. E.; Carver, M. P.; Coppoc, G. L.; Carlton, W. W.; Lantz, G. C.; Shy-Modjeska, J., 1984: Pharmacokinetics and comparative nephrotoxicity of fixed dose vs. fixed interval reduction of gentamicin dosage in subtotal nephrectomized dogs

Mcneil J.J.; Drummer O.H.; Anderson A.I.E.; Louis W.J., 1986: Pharmacokinetics and concentration effect relationships of bevantolol ci 775 in normal volunteers

Ochs H.R.; Greenblatt D.J.; Burstein E.S.; Eichelkraut W.; Hahn N., 1988: Pharmacokinetics and csf entry of flurazepam in dogs

Iguchi, H.; Tone, H.; Kiyosaki, T.; Ishikura, T.; Takeuchi, T.; Umezawa, H., 1986: Pharmacokinetics and disposition of 2 r 4' o tetrahydropyranyladriamycin in dogs

Tone, H.; Iguchi, H.; Fujigaki, M.; Nishio, M.; Esumi, Y.; Takaichi, M.; Tsutsumi, S.; Yokoshima, T., 1986: Pharmacokinetics and disposition of a new anticancer antibiotic 2 r 4' o tetrahydropyranyladriamycin in rats distribution and excretion after a single administration

Tone, H.; Iguchi, H.; Shomura, T.; Komiya, I.; Nishio, M., 1986: Pharmacokinetics and disposition of a new antitumor antibiotic 2 r 4' o tetrahydropyranyladriamycin in rats distribution and excretion after multiple administration

Singh H.; Chaudhary A.K., 1985: Pharmacokinetics and disposition of chandonium iodide in monkey macaca mulatta

Singh H.; Chaudhary A.K., 1985: Pharmacokinetics and disposition of chandonium iodide in rat

Anderson P.; Bluhm G.; Ehrnebo M.; Herngren L.; Jacobson B., 1985: Pharmacokinetics and distribution of flucloxacillin in pacemaker patients

Malik J.K.; Srivastava A.K., 1987: Pharmacokinetics and dosage of sulfadimidine in cross bred calves

Egorin M.J.; Van Echo D.A.; Tipping S.J.; Olman E.A.; Whitacre M.Y.; Thompson B.W.; Aisner J., 1984: Pharmacokinetics and dosage reduction of cis diammine 1 1 cyclobutanedicarboxylatoplatinum in patients with impaired renal function

Singh M.K.; Jayachandran C.; Singh S.D.; Banerjee N.C., 1988: Pharmacokinetics and dosage regimen of oxytetracycline following intramuscular administration in buffaloes

Bosso J.A.; Townsend P.L.; Herbst J.J.; Matsen J.M., 1985: Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients

Lakings D.B.; Novak E.; Friis J.M.; Lunan C.M.; Paxton L.M., 1986: Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration

Huang Y C.; Colaizzi J.L.; Bierman R.H.; Woestenborghs R.; Heykants J.J.P., 1986: Pharmacokinetics and dose proportionality of domperidone in healthy volunteers

Hilbert J.; Radwanski E.; Weglein R.; Luc V.; Perentesis G.; Symchowicz S.; Zampaglione N., 1987: Pharmacokinetics and dose proportionality of loratadine

Koeppe P.; Hoeffler D.; Strobel K., 1987: Pharmacokinetics and dose recommendations of carumonam in renal failure

Hoeffler D.; Pech M.; Koeppe P.; Metz R.; Soergel F., 1988: Pharmacokinetics and dose recommendations of fleroxacin in subjects with normal and impaired renal function

Jensen H.K.; Nielsen Kudsk F., 1988: Pharmacokinetics and dynamic effects of diltiazem in the isolated guinea pig heart

Gladziwa U.; Klotz U.; Krishna D.R.; Schmitt H.; Gloecker W.M.; Mann H., 1988: Pharmacokinetics and dynamics of famotidine in patients with renal failure

Ochs H.R.; Hajdu P.; Greenblatt D.J., 1986: Pharmacokinetics and dynamics of penbutolol in humans evidence for pathway specific stereoselective clearance

Todd E.L.; Abernethy D.R., 1986: Pharmacokinetics and dynamics of racemic verapamil in lean and obese zucker rats

Zetler G.; Baumann G.H., 1985: Pharmacokinetics and effects of haloperidol in the isolated mouse

Ho L.T.; Chen R.L.; Chou T.Y.; Fong J.C.; Wang P.S.; Chou C.K., 1986: Pharmacokinetics and effects of intravenous infusion of somatostatin in normal subjects a two compartment open model

Brooks P.M.; Mccredie M.; Prowse M.; Podgorski M.; Forrest M.; Munro I.; Boutagy J.; Pei Ling L., 1986: Pharmacokinetics and effects of isoxicam on renal function in patients with renal insufficiency

Larsson R.; Liedholm H.; Andersson K.E.; Keane M.A.; Henry G., 1986: Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment

Verstraete M.; Su C.A.P.F.; Tanswell P.; Feuerer W.; Collen D., 1986: Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue type plasminogen activator in healthy volunteers

Navarro A.S.; Lanao J.M.; Dominguez Gil A., 1985: Pharmacokinetics and efficacy indices of dibekacin following its administration by different routes

Taylor W.B.; Proctor S.J.; Bateman D.N., 1984: Pharmacokinetics and efficacy of high dose metoclopramide given by continuous infusion for the control of cytotoxic drug induced vomiting

Canal P.; Bugat R.; Rokoszak B.; Berg D.; Soula G.; Roche H., 1986: Pharmacokinetics and efficacy of intravenous and intraperitoneal vm 26 chemotherapy in mice bearing krebs ii ascitic tumors

Shaw D.D.; Kido D.K.; Stroshane R.M.; Palace G.P.; Sahler L., 1985: Pharmacokinetics and excretion of iohexol after lumbar myelography in man

Ferraiolo B.L.; Halldin M.M.; Asscher Y.; Akita Y.; Melmon K.L.; Benet L.Z.; Castagnoli N.Jr, 1987: Pharmacokinetics and excretion of unique beta adrenergic agonists

Edgar B.; Collste P.; Haglund K.; Regardh C G., 1987: Pharmacokinetics and hemodynamic effects of felodipine as monotherapy in hypertensive patients

Kleinbloesem C.H.; Van Brummelen P.; Faber H.; Breimer D.D., 1987: Pharmacokinetics and hemodynamic effects of long term nifedipine treatment in hypertensive patients

Macmahon B.; Bakshi M.; Branagan P.; Kelly J.G.; Walsh M.J., 1985: Pharmacokinetics and hemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure

Wilson H.; Rocci M.L.Jr; Weber K.T.; Andrews V.; Likoff M.J., 1987: Pharmacokinetics and hemodynamics of amrinone in patients with chronic cardiac failure of diverse etiology

Newman E.M.; Doroshow J.H.; Forman S.J.; Blume K.G., 1988: Pharmacokinetics and high dose etoposide

Marone C.; Reubi F.C.; Perisic M.; Lahn W., 1984: Pharmacokinetics and high doses of piretanide in moderate to severe renal failure

Henner W.D.; Peters W.P.; Eder J.P.; Antman K.; Schnipper L.; Frei E.IIi, 1986: Pharmacokinetics and immediate effects of high dose carmustine in man

Calvo M.V.; Nalda M.A.; Lanao J.M.; Dominguez Gil A.; Carrasco S., 1985: Pharmacokinetics and initial distribution of a new neuroleptic agent picobenzide m 14012 4

Roth W., 1988: Pharmacokinetics and laxative effect of bisacodyl after administration of various dosage forms

Yang, H. M.; Reisfeld, R. A., 1988: Pharmacokinetics and mechanism of action of a doxorubicin monoclonal antibody 9.2.27 conjugate directed to a human melanoma proteoglycan

Brock N.; Hilgard P.; Pohl J.; Ormstad K.; Orrenius S., 1984: Pharmacokinetics and mechanism of action of detoxifying low molecular weight thiols

Misra M.; Athar M.; Chandra S.; Hasan S.K.; Srivastava R.C., 1987: Pharmacokinetics and metabolic disposition of nickel in poisoned rats effect of chelating drugs

Groop L.; Wahlin Boll E.; Groop P H.; Totterman K J.; Melander A.; Tolppanen E M.; Fyhrqvist F., 1985: Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics

Bret M.C.; Chanal J.L.; Marignan R.; Monnier L.; Poitou P.; Cousse H.; Fauran F., 1984: Pharmacokinetics and metabolic study of itanoxone in adult

Tse F.L.S.; Orwig B.A.; Jaffe J.M.; Dain J.G., 1987: Pharmacokinetics and metabolism of alpha dimethylaminomethyl 2 3 ethyl 5 methyl 4 isoxazolyl 1h indole 3 methanol a hypoglycemic agent in man

Lin C C.; Lim J.; Radwanski E.; Kum H K.; Marco A.; Lapiguera A.; Digiore C.; Symchowicz S., 1987: Pharmacokinetics and metabolism of an intravenously administered penem sch 34343 in humans

Makovec F.; Chiste R.; Peris W.; Setnikar I., 1987: Pharmacokinetics and metabolism of carbon 14 proglumetacin after oral administration in the rat

Lin C C.; Kim H K.; Marco A.; Radwanski E.; Symchowicz S., 1986: Pharmacokinetics and metabolism of carbon 14 rosaramicin in dogs

Wood S.G.; John B.A.; Chasseaud L.F.; Brodie R.R.; Baker J.M.; Faulkner J.K.; Wood B.A.; Darragh A.; Lambe R.F., 1986: Pharmacokinetics and metabolism of carbon 14 tinidazole in humans

Horvath I.P.; Csetenyi J.; Kerpel Fronius S.; Hegedus L.; Kanyar B.; Eckhardt S., 1986: Pharmacokinetics and metabolism of dianhydrogalactitol in patients a comparison with the human disposition of dibromodulcitol

Samuel, J.; Gill, M. J.; Iwashina, T.; Tovell, D. R.; Tyrrell, D. L.; Knaus, E. E.; Wiebe, L. I., 1986: Pharmacokinetics and metabolism of e 5 2 iodine 131 iodovinyl 2' deoxyuridine in dogs

Mross K.; Maessen P.; Van Der Vijgh W.J.F.; Gall H.; Boven E.; Pinedo H.M., 1988: Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans

Vrignaud, P.; Eghbali, H.; Hoerni, B.; Iliadis, A.; Robert, J., 1985: Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in hodgkin's patients

Vollmer K O.; Von Hodenberg A.; Koelle E.U., 1986: Pharmacokinetics and metabolism of gabapentin in rat dog and man

Dubois J.; Atassi G.; Hanocq M.; Abikhalil F., 1986: Pharmacokinetics and metabolism of hexamethylmelamine in mice after ip administration

Abshagen U.; Betzien G.; Endele R.; Kaufmann B.; Neugebauer G., 1985: Pharmacokinetics and metabolism of isosorbide dinitrate after intravenous and oral administration

Hildebrand M.; Krause W.; Kuehne G.; Hoyer G A., 1987: Pharmacokinetics and metabolism of mespirenone a new aldosterone antagonist in rat and cynomolgus monkey

Regardh C G.; Gabrielsson M.; Hoffman K J.; Lofberg I.; Skanberg I., 1985: Pharmacokinetics and metabolism of omeprazole in animals and man an overview

Robert J.; David M.; Huet S.; Chauvergne J., 1988: Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients

Mikus G.; Ha H.R.; Vozeh S.; Zekorn C.; Follath F.; Eichelbaum M., 1986: Pharmacokinetics and metabolism of quinidine in extensive and poor metabolizers of sparteine

Lin C C.; Chung M.; Gural R.; Schuessler D.; Kim H K.; Radwanski E.; Marco A.; Digiore C.; Symchowicz S., 1984: Pharmacokinetics and metabolism of rosaramicin in humans

Gharib A.; Sarda N.; Chabannes B.; Pacheco H., 1985: Pharmacokinetics and metabolism of s adenosyl l homocysteine in rats and dog

Hutchings M.J.; Paull J.D.; Wilson Evered E.; Morgan D.J., 1987: Pharmacokinetics and metabolism of salbutamol in premature labor

Rovei V.; Benedetti M.S.; Daniel C.; Moulin A.; Donath A., 1985: Pharmacokinetics and metabolism of the antiarrhythmic carocainide in man

Brodfuehrer J.I.; Wilke T.J.; Powis G., 1988: Pharmacokinetics and metabolism of the antitumor agent sulfamic acid 1 7 hepatanediyl ester sulfamic acid diester in the mouse and beagle dog

Felder T.B.; Mclean M.A.; Vestal M.L.; Lu K.; Farquhar D.; Legha S.S.; Shah R.; Newman R.A., 1987: Pharmacokinetics and metabolism of the antitumor drug amonafide nsc 308847 in humans

Assandri A.; Bernareggi A.; Ripamonti A.; Perazzi A.; Toja E., 1985: Pharmacokinetics and metabolism of tomoxiprole a new analgesic antiinflammatory agent in the rat

Neugebauer G.; Besenfelder E.; Moellendorff E.V., 1988: Pharmacokinetics and metabolism of torasemide in man

Friis C.; Gyrd Hansen N.; Nielsen P.; Nordholm L.; Rasmussen F., 1984: Pharmacokinetics and metabolism of trimethoprim in neonatal and young pigs

Giacoia G.P.; Schentag J.J., 1986: Pharmacokinetics and nephrotoxicity of continuous intravenous infusion of gentamicin in low birth weight infants

Henny F.C.; Kleinbloesem C.H.; Moolenaar A.J.; Paul L.C.; Breimer D.D.; Van Es L.A., 1985: Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients

Guizzardi S.; Mastacchi R.; Govoni P.; Milani M.R.; Barbanti M.; Ruggeri A., 1987: Pharmacokinetics and organ distribution in rats of a low molecular weight heparin

Braslis K.G.; Shulkes A.; Fletcher D.R.; Hardy K.J., 1988: Pharmacokinetics and organ specific metabolism of calcitonin gene related peptide in sheep

Fu M.; Hung J S.; Yeh S J.; Lin F C.; Hsu R.S.; Wu D., 1987: Pharmacokinetics and pharmacodynamic effects of aqueous diltiazem in healthy humans

Traeger A.; Haentze R.; Penzlin M.; Krombholz B.; Reinhardt M.; Keil E.; Jorke D., 1985: Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosis

Tsujiyama T.; Goto S.; Kawata M.; Suzuki N., 1986: Pharmacokinetics and pharmacodynamic evaluation of gelatin microcapsule containing piretanide in beagle dogs

Vinceneux P.; Canal M.; Domart Y.; Roux A.; Cascio B.; Orofiamma B.; Larribaud J.; Flouvat B.; Carbon C., 1986: Pharmacokinetics and pharmacodynamic interactions between nifedipine and propranolol or betaxolol

Yacobi A.; Lai C M.; Levy G., 1984: Pharmacokinetics and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats

Mcinnes G.T.; Bunting E.A.; Ings R.M.J.; Robinson J.; Ankier S.I., 1985: Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam a new benzodiazepine hypnotic

Krause, W.; Sauerbrey, N.; Graef, K. J., 1986: Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative bromerguride

Frey B.M.; Walker C.; Frey F.J.; De Weck A.L., 1984: Pharmacokinetics and pharmacodynamics of 3 different prednisolone prodrugs effect on circulating lymphocyte subsets and function

Van Der Vet A.P.H.; Drost R.H.; Kreukniet J.; Maes R.A.A., 1984: Pharmacokinetics and pharmacodynamics of 3 sustained release theophylline preparations 350 milligram theograd 350 milligram theolair retard and 300 milligram theodur in steady state in healthy volunteers and asthmatics 1 theophylline plasma levels

Van-Der-Vet, A. P. H.; Kreukniet, J.; Drost, R. H.; Maes, R. A. A., 1985: Pharmacokinetics and pharmacodynamics of 3 sustained release theophylline preparations theograd 350 milligrams theolair retard and 300 milligrams theolin retard in steady state in 6 normals and 6 patients with chronic asthmatic bronchitis 2. lung function

Witte, P. U.; Irmisch, R.; Hajdu, P.; Metzger, H., 1984: Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor hoe 498 n 1 s carbethoxy 3 phenylpropyl s alanyl cis endo 2 azabicyclo 3.3.0 octan 3 s carboxylic acid in healthy subjects

Shafer A.; Sung M L.; White P.F., 1986: Pharmacokinetics and pharmacodynamics of alfentanil infusions during general anesthesia

Smith R.B.; Kroboth P.D.; Vanderlugt J.T.; Phillips J.P.; Juhl R.P., 1984: Pharmacokinetics and pharmacodynamics of alprazolam after oral and intravenous administration

Woosley R.L., 1987: Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure

Schran H.F.; Tse F.L.S.; Bhuta S.I., 1985: Pharmacokinetics and pharmacodynamics of bromocriptine in the rat

Fujimura, A.; Kajiyama, H.; Ebihara, A.; Iwashita, K.; Nomura, Y.; Kawahara, Y., 1986: Pharmacokinetics and pharmacodynamics of captopril in patients undergoing continuous ambulatory peritoneal dialysis

Johnson C.A.; Zimmerman S.W.; Reitberg D.P.; Whall T.J.; Leggett J.E.; Craig W.A., 1988: Pharmacokinetics and pharmacodynamics of cefoperazone sulbactam in patients on continuous ambulatory peritoneal dialysis

Lloyd C.W.; Martin W.J.; Taylor B.D.; Hauser A.R., 1985: Pharmacokinetics and pharmacodynamics of cimetidine and metabolites in critically ill children

Lebel M.; Bergeron M.G.; Vallee F.; Fiset C.; Chasse G.; Bigonesse P.; Rivard G., 1986: Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

Guay D.R.P.; Awni W.M.; Findlay J.W.A.; Halstenson C.E.; Abraham P.A.; Opsahl J.A.; Jones E.C.; Matzke G.R., 1988: Pharmacokinetics and pharmacodynamics of codeine in end stage renal disease

Blomqvist I.; Westergren G.; Sandberg A.; Jonsson U.E.; Lundborg P., 1988: Pharmacokinetics and pharmacodynamics of controlled release metoprolol a comparison with atenolol

Imai Y.; Abe K.; Sasaki S.; Nihei M.; Sekino H.; Yoshinaga K., 1986: Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients

Matteo R.S.; Backus W.W.; Mcdaniel D.D.; Brotherton W.P.; Abraham R.; Diaz J., 1985: Pharmacokinetics and pharmacodynamics of d tubocurarine and metocurine in the elderly

Pilbrant A.; Norlen L.J., 1985: Pharmacokinetics and pharmacodynamics of emepronium bromide cetiprin after intravenous administration in man

Schwatz J.B.; Taylor A.; Abernethy D.; O'meara M.; Farmer J.; Young J.; Nelson E.; Pool J.; Mitchell J.R., 1985: Pharmacokinetics and pharmacodynamics of enalapril in patients with congestive heart failure and patients with hypertension

Schuettler J.; Hornchen U.; Stoeckel H.; Hahn N., 1987: Pharmacokinetics and pharmacodynamics of epinephrine administered endobronchially

Achari R.; Drissel D.; Hulse J.D.; Bell V.; Turlapaty P.; Laddu A.; Matier W.L., 1987: Pharmacokinetics and pharmacodynamics of flestolol a new short acting beta adrenergic receptor antagonist

Muehlberg W.; Platt D.; Neubig E., 1986: Pharmacokinetics and pharmacodynamics of furosemide in geriatric patients

Derendorf H.; Moellmann H.; Gruener A.; Haack D.; Gyselby G., 1986: Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra articular administration

Flagstad A.; Nielsen P.; Trojaborg W., 1986: Pharmacokinetics and pharmacodynamics of guanidine hydrochloride in an hereditary myasthenia gravis like disorder in dogs

Kuehnel H J.; Guenther K.; Stein G.; Hoffmann Traeger A., 1987: Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome

Bichler J.; Fichtl B.; Siebeck M.; Fritz H., 1988: Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration

Brazzell R.K.; Khoo K C.; Szuna A.J.; Sandor D.; Aogaichi K.; Wills R.J., 1985: Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers

Macgilchrist A.J.; Birnie G.G.; Cook A.; Scobie G.; Murray T.; Watkinson G.; Brodie M.J., 1986: Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis

Marino M.R.; Dey M.; Garg D.C.; Jallad N.S.; Dorick D.M.; Martinez J.J.; Weidler D.J., 1987: Pharmacokinetics and pharmacodynamics of long acting propranolol 60 mg capsules a comparative evaluation

Hall R.I.; Szlam F.; Hug C.C.Jr, 1988: Pharmacokinetics and pharmacodynamics of midazolam in the enflurane anesthetized dog

Benotti J.R.; Lesko L.J.; Mccue J.E.; Alpert J.S., 1985: Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure

Gutierrez L.M.; Lesko L.J.; Whipps R.; Carliner N.; Fisher M., 1986: Pharmacokinetics and pharmacodynamics of nifedipine in patients at steady state

Walley T.J.; Heagerty A.M.; Woods K.L.; Bing R.F.; Pohl J.E.F.; Barnett D.B., 1987: Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers

Vargas R.; Ryan J.; Mcmahon F.G.; Regel G.; Offen W.W.; Matsumoto C., 1988: Pharmacokinetics and pharmacodynamics of oral nizatidine

Liu L T.; Huang R H., 1988: Pharmacokinetics and pharmacodynamics of p aminopropiophenone in rabbits

Liu L T.; Huang R H., 1988: Pharmacokinetics and pharmacodynamics of p hydroxylaminopropiophenone

Rakhit A.; Hurley M.E.; Tipnis V.; Coleman J.; Rommel A.; Brunner H.R., 1986: Pharmacokinetics and pharmacodynamics of pentopril a new angiotensin converting enzyme inhibitor in humans

Somani S.M.; Khalique A., 1987: Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration

Whiteman P.D.; Fowle A.S.E.; Hamilton M.J.; Peck A.W.; Bye A.; Dean K.; Webster A., 1985: Pharmacokinetics and pharmacodynamics of procyclidine in man

Giani P.; Landolina M.; Giudici V.; Bianchini C.; Ferrario G.; Marchi S.; Riva E.; Latini R., 1988: Pharmacokinetics and pharmacodynamics of propafenone during acute and chronic administration

Shafer A.; Doze V.A.; Shafer S.L.; White P.F., 1988: Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia

Rakhit A.; Guentert T.W.; Holford N.H.G.; Verhoeven J.; Riegelman S., 1984: Pharmacokinetics and pharmacodynamics of quinidine and its metabolite quinidine n oxide in beagle dogs

Krause W.; Krais T., 1987: Pharmacokinetics and pharmacodynamics of radio labeled iloprost in elderly volunteers

De Mey C.; Enterling D.; Brendel E.; Wesche H., 1988: Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine quinidine and their combination in normal man

Yoburn B.C.; Chen J.; Huang T.; Inturrisi C.E., 1985: Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat

Yoburn B.C.; Cohen A.H.; Inturrisi C.E., 1986: Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat

Krause W.; Dorow R.; Nieuweboer B.; Hasan S.H., 1984: Pharmacokinetics and pharmacodynamics of the ergot derivative transdihydrolisuride in man

Klimmek R.; Eyer P., 1986: Pharmacokinetics and pharmacodynamics of the oxime hi6 in dogs

Krause W.; Krais T., 1986: Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man

Muehlberg W.; Platt D.; Bauer M.; Salzner U., 1987: Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases

Holford N.H.G.; Clements P.; Collier P.; Orie N.G.M.; Van Bork L.E.; Jonkman J.H.G., 1987: Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients

Hla K.K.; Henry J.A.; Latham A.N., 1987: Pharmacokinetics and pharmacodynamics of two formulations of verapamil

Bottorff M.B.; Hoon T.J.; Rodman J.H.; Gerlach P.A.; Ramanathan K.B., 1988: Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension

Meistelman, C.; Agoston, S.; Kersten, U. W.; Saint-Maurice, C.; Bencini, A. F.; Loose, J. P., 1986: Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized children

Yajima C.; Sugai N.; Inada Y., 1985: Pharmacokinetics and pharmacodynamics of vecuronium and pancuronium in anesthetized man

Lebrault C.; Duvaldestin P.; Henzel D.; Chauvin M.; Guesnon P., 1986: Pharmacokinetics and pharmacodynamics of vecuronium in patients with cholestasis

Lebrault C.; Berger J.L.; D'hollander A.A.; Gomeni R.; Henzel D.; Duvaldestin P., 1985: Pharmacokinetics and pharmacodynamics of vecuronium org nc 45 in patients with cirrhosis

Scheen A.J.; Jaminet C.; Luyckx A.S.; Lefebvre P.J., 1987: Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide hb 419 and hb 420 in non insulin dependent type 2 diabetes

Gepts E.; Heytens L.; Camu F., 1986: Pharmacokinetics and placental transfer of intravenous and epidural alfentanil in parturient women

Likitnukul S.; Mccraken G.H.Jr; Threlkeld N.; Darabi A.; Olsen K., 1987: Pharmacokinetics and plasma bactericidal activity of aztreonam in low birth weight infants

Sainsbury E.J.; Fitzpatrick D.; Ikram H.; Nicholls M.G.; Espiner E.A.; Ashley J.J., 1985: Pharmacokinetics and plasma concentration effect relationships of prenalterol in cardiac failure

Aronoff G.R.; Wolen R.L.; Obermeyer B.D.; Black H.R., 1986: Pharmacokinetics and protein binding of cefamandole and its 1 methyl 1h tetrazole 5 thiol side chain in subjects with normal and impaired renal function

Ohashi K.; Tsunoo M.; Tsuneoka K., 1986: Pharmacokinetics and protein binding of cefazolin and cephalothin in patients with cirrhosis

Sintov A.; Bialer M.; Yagen B., 1988: Pharmacokinetics and protein binding of trichothecene mycotoxins t 2 toxin and ht 2 toxin in dogs

Terziivanov D.; Gerova Z.; Vlahov V.; Merdzhanov A.; Damjanov D., 1986: Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy

Nouws J.F.M.; Vree T.B.; Termond E.; Lohuis J.; Van Lith P.; Binkhorst G.J.; Breukink H.J., 1986: Pharmacokinetics and renal clearance of oxytetracycline after intravenous and intramuscular administration to dairy cows

Mevius D.J.; Vellenga L.; Breukink H.J.; Nouws J.F.M.; Vree T.B.; Driessens F., 1988: Pharmacokinetics and renal clearance of oxytetracycline in piglets following intravenous and oral administration

Nouws J.F.M.; Firth E.C.; Vree T.B.; Baakman M., 1987: Pharmacokinetics and renal clearance of sulfamethazine sulfamerazine and sulfadiazine and their n 4 acetyl and hydroxy metabolites in horses

Allain P.; Mauras Y.; Chaleil D.; Simon P.; Ang K.S.; Cam G.; Le Mignon L.; Simon M., 1987: Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with hemochromatosis

Kuo, B. S.; Ritschel, W. A., 1986: Pharmacokinetics and reversible biotransformation of sulfinpyrazone and its metabolites in rabbits i. single dose study

Kuo, B. S.; Ritschel, W. A., 1986: Pharmacokinetics and reversible biotransformation of sulfinpyrazone and its metabolites in rabbits ii. multiple dose study

Mulhall A.; De Louvois J.; James J., 1985: Pharmacokinetics and safety of ceftriaxone in the neonate

Fletcher C.; Chinnock B.J.; Chace B.; Balfour H.H.Jr, 1988: Pharmacokinetics and safety of high dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation

Uematsu T.; Itaya T.; Nishimoto M.; Takiguchi Y.; Mizuno A.; Nakashima M.; Yoshinobu K.; Hasebe T., 1988: Pharmacokinetics and safety of levo carnitine infused iv in healthy subjects

Rootman D.S.; Jantzen J.A.; Gonzalez J.R.; Fischer M.J.; Beuerman R.; Hill J.M., 1988: Pharmacokinetics and safety of transcorneal iontophoresis of tobramycin in the rabbit

Hoeffken G.; Tetzel H.; Koeppe P.; Lode H., 1985: Pharmacokinetics and serum bactericidal activity of ticarcillin and clavulanic acid

Boeckh M.; Lode H.; Borner K.; Hoeffken G.; Wagner J.; Koeppe P., 1988: Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers

Smith M.J.; White L.O.; Bowyer H.; Willis J.; Hodson M.E.; Batten J.C., 1986: Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

Dobbs B.R.; Gazeley L.R.; Stewart I.A.; Edwards I.R., 1988: Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven days

Pierce D.M.; Abrams S.M.L.; Franklin R.A., 1987: Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6 hydroxyindoramin in healthy subjects

Verstraete M.; Bounameaux H.; De Cock F.; Van De Werf F.; Collen D., 1985: Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue type plasminogen activator in humans

Mehta A.C., 1987: Pharmacokinetics and the analytical chemist

Boiko S.S.; Bobkov Yu G.; Neznamov G.G.; Serebryakova T.V., 1986: Pharmacokinetics and the clinical effect of bemitil following a single administration

Todorov I.N.; Sizova S.T.; Kosaganova N.Yu; Mitrokhin Yu I.; German A.V.; Mitrofanova M.A., 1984: Pharmacokinetics and the mechanism of the effect of eleutherococcus glycosides the effect of the extract on the metabolism and biosynthesis of protein in some organs and tissues of rats

Shohet I.; Yellin A.; Meyerovitch J.; Rubinstein E., 1987: Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model

De Cuyper H.; Bollen J.; Van Praag H.M.; Verstraeten D., 1986: Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration

Cambier P.; Van De Werf F.; Larsen G.R.; Collen D., 1988: Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue type plasminogen activator lacking the finger and growth factor domains in dogs with copper coil induced coronary artery thrombosis

Collen D.; Stassen J M.; Larsen G., 1988: Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue type plasminogen activator in rabbits

Xiang X Q.; Wang Q N.; Liu Y H.; Jiang Y F.; Du J Z.; Sheng J Q., 1987: Pharmacokinetics and tissue concentration of china made ceftriaxone in dogs

Rosenblum M.G.; Hortobagyi G.N., 1986: Pharmacokinetics and tissue disposition of the biological response modifier bay i 7433 copovithane in patients with cancer

Michiels M.; Van Peer A.; Woestenborghs R.; Heykants J., 1986: Pharmacokinetics and tissue distribution of astemizole in the dog

Rolland A., 1988: Pharmacokinetics and tissue distribution of doxorubicin loaded polymethacrylic nanoparticles in rabbits

Michiels M.; Monbaliu J.; Meuldermans W.; Hendriks R.; Geerts R.; Woestenborghs R.; Heykants J., 1988: Pharmacokinetics and tissue distribution of ketanserin in rat rabbit and dog

Lautersztain J.; Perez Soler R.; Khokhar A.R.; Newman R.A.; Lopez Berestein G., 1986: Pharmacokinetics and tissue distribution of liposome encapsulated cis bis n decyliminodiacetato 1 2 diaminocyclohexaneplatinum ii

De Bernardis E.; Bonaccorsi S.; Carlino S.; Picari M.; Rizza V., 1988: Pharmacokinetics and tissue distribution of ofloxacin in human subjects during a multiple dose regimen

Grondel, J. L.; Nouws, J. F. M.; De-Jong, M.; Schutte, A. R.; Driessens, F., 1987: Pharmacokinetics and tissue distribution of oxytetracycline in carp cyprinus carpio l. following different routes of administration

Ferraiolo B.L.; Moore J.A.; Crase D.; Gribling P.; Wilking H.; Baughman R.A., 1988: Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor alpha in mice

Michiels M.; Monbaliu J.; Hendriks R.; Geerts R.; Woestenborghs R.; Heykants J., 1987: Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat rabbit and dog

Huo Y S.; Zhang S C.; Zhou D.; Yao D L.; You G Y.; Zhang H W.; Ma S W.; Mo Q Z.; Gong B.; Yi M G., 1986: Pharmacokinetics and tissue distribution of tritiated ginsenoside r g 1

Mcnulty C.A.M.; Garden G.M.F.; Ashby J.; Wise R., 1985: Pharmacokinetics and tissue penetration of carumonam a new synthetic monobactam

Webberley J.M.; Andrews J.M.; Ashby J.P.; Mcleod A.; Wise R., 1987: Pharmacokinetics and tissue penetration of orally administered pefloxacin

Wise R.; Kirkpatrick B.; Ashby J.; Griggs D.J., 1987: Pharmacokinetics and tissue penetration of ro 23 6240 a new trifluoroquinolone

Wise R.; Kirkpatrick B.; Ashby J.; Andrews J.M., 1987: Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing

Tartaglione T.A.; Raffalovich A.C.; Poynor W.J.; Espinel Ingroff A.; Kerkering T.M., 1986: Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses

Petty B.G.; Whitley R.J.; Liao S.; Krasny H.C.; Rocco L.E.; Davis L.G.; Lietman P.S., 1987: Pharmacokinetics and tolerance of desciclovir a prodrug of acyclovir in healthy human volunteers

Shah I.; Band J.; Samson M.; Young J.; Robinson R.; Bailey B.; Lerner A.M.; Prasad A.S., 1984: Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha 2 interferon in patients with malignancies

Young J.A.; Howell S.B.; Green M.R., 1984: Pharmacokinetics and toxicity of 5 day continuous infusion of vinblastine

Parker R.I.; Forman E.N.; Krumm K.F.; Abeel M.J.; Martin H.F., 1986: Pharmacokinetics and toxicity of frequent intermediate dose methotrexate infusions

Keyler D.E.; Pentel P.R.; Haughey D.B., 1987: Pharmacokinetics and toxicity of high dose human alpha 1 acid glycoprotein infusion in the rat

Pentel P.R.; Keyler D.E.; Gilbertson D.G.; Ruth G.; Pond S.M., 1988: Pharmacokinetics and toxicity of high doses of antibody fab fragments in rats

Zakris E.L.; Dewhirst M.W.; Riviere J.E.; Hoopes P.J.; Page R.L.; Oleson J.R., 1987: Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia

Garre M.L.; Relling M.V.; Kalwinsky D.; Dodge R.; Crom W.R.; Abromowitch M.; Pui C H.; Evans W.E., 1987: Pharmacokinetics and toxicity of methotrexate in children with down syndrome and acute lymphocytic leukemia

Kerpel Fronius S.; Verwey J.; Stuurman M.; Kanyar B.; Lelieveld P.; Pinedo H.M., 1988: Pharmacokinetics and toxicity of mitomycin c in rodents given alone in combination or after induction of microsomal drug metabolism

Klimmek R.; Eyer P., 1985: Pharmacokinetics and toxicity of the oxime hgg 12 in dogs

Zylicz Z.; Wagener D.J.T.; Del Moral P.F.; Van Rennes H.; Wessels J.M.C.; Winograd B.; Van Der Kleijn E.; Vree T.B.; Van Haelst U.; Et Al, 1987: Pharmacokinetics and toxicology of sparsomycin in beagle dogs

Arakawa S.; Matsui T.; Maeda H.; Sako M.; Sugino M.; Ka S.; Nakasuji T.; Fujii A.; Kamidono S.; Et Al, 1988: Pharmacokinetics and urinary excretion of aspoxicillin after consecutive administration at a dose of 4 gram

Ferslew K.E.; Daigneault E.A.; Aten E.M.; Roseman J.M., 1984: Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate

Meinhold H.; Finke R.; Bogner U.; Schleusener H., 1987: Pharmacokinetics and urinary excretion of orally administered diiodotyrosine

Olive P.L.; Chaplin D.J.; Durand R.E., 1985: Pharmacokinetics binding and distribution of hoechst 33342 in spheroids and murine tumors

Pashov D.; Mutafchieva R.; Drumev D.; Koichev K.B.; Avramova N., 1984: Pharmacokinetics bioavailability and drug residues of sulfadoxin and trimethoprim applied in combination to calves

Arendt R.M.; Greenblatt D.J.; Dejong R.H.; Bonin J.D.; Abernethy D.R., 1984: Pharmacokinetics central nervous system uptake and lipid solubility of propranolol acebutolol and sotalol

Baker J.R.J.; Kemmenoe B.H.; Mcmartin C.; Peters G.E., 1984: Pharmacokinetics distribution and elimination of a synthetic octapeptide analog of somatostatin in the rat

Heykants J.; Michiels M.; Woestenborghs R.; Awouters F.; Leysen J.E.; Schuurkes J.; Van Nueten J.M., 1988: Pharmacokinetics evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat

Arnaud M.J., 1985: Pharmacokinetics in animal chronic toxicological studies

Anderson P.; Noher H.; Swahn C.G., 1984: Pharmacokinetics in baclofen overdose

Lee, M. G.; Lui, C. Y.; Chen, M. L.; Chiou, W. L., 1984: Pharmacokinetics in blood 4. unusual distribution storage effect and metabolism of methotrexate

Takahashi K.; Wada T.; Higashi Y.; Yata N., 1985: Pharmacokinetics in hepatic transport of amaranth in rats intoxicated with carbon tetrachloride and alpha naphthylisothiocyanate

Whittemore A.S.; Grosser S.C.; Silvers A., 1986: Pharmacokinetics in low dose extrapolation using animal cancer data

Runci F.M.; Cerretani D.; Cerri D.; Segre G., 1984: Pharmacokinetics in man of glysolamide a low dose oral antidiabetic drug

Iwai N.; Sasaki A.; Taneda Y.; Mizoguchi F.; Nakamura H.; Kawamura M.; Tauchi N.; Ozaki T.; Ichikawa T.; Matsui S., 1987: Pharmacokinetics in neonates and infants following administration of amikacin

Weiss M., 1985: Pharmacokinetics in target tissues

Rinetti M.; Cerutti R.; Cisternino M.; Zinelli L.C., 1984: Pharmacokinetics in the elderly

Lundin S.; Akerlund M.; Fagerstrom P O.; Hauksson A.; Melin P., 1986: Pharmacokinetics in the human of a new synthetic vasopressin and oxytocin uterine antagonist

Eriksson U.G.; Schuhmann G.; Brasch R.C.; Tozer T.N., 1988: Pharmacokinetics in the rat and the dog of a nonionic nitroxide contrast agent for magnetic resonance imaging

Naber, K. G.; Dette, G. A.; Kees, F.; Knothe, H.; Grobecker, H., 1986: Pharmacokinetics in vitro activity therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections

Gombar C.T.; Straub K.; Levandoski P.; Gutzait L.; Swagzdis J.; Garvie C.; Joseph G.; Potts B.D.; Mico B.A., 1986: Pharmacokinetics metabolism and disposition of 6 chloro 2 3 4 5 tetrahydro 3 methyl 1h 3 benzazepine skf 86466 in rats and dogs

Lees P.; Ayliffe T.; Maitho T.E.; Taylor J.B.O., 1988: Pharmacokinetics metabolism and excretion of phenylbutazone in cattle following intravenous intramuscular and oral administration

Nouws J.F.M.; Mevius D.; Vree T.B.; Baakman M.; Degen M., 1988: Pharmacokinetics metabolism and renal clearance of sulfadiazine sulfamerazine and sulfamethazine and of their n 4 acetyl an hydroxy metabolites in calves and cows

Vree T.B.; Hekster Y.A.; Nouws J.F.M.; Baakman M., 1986: Pharmacokinetics metabolism and renal excretion of sulfadimidine and its n 4 acetyl and hydroxy metabolites in humans

Vree T.B.; Hekster Y.A.; Tijhuis M.W.; Termond E.F.S.; Nouws J.F.M., 1986: Pharmacokinetics metabolism and renal excretion of sulfatroxazole and its 5 hydroxy and n 4 acetyl metabolites in man

Liliemark, J. O.; Paul, C. Y.; Gahrton, C. G.; Peterson, C. O., 1985: Pharmacokinetics of 1 beta d arabinofuranosylcytosine 5' triphosphate in leukemic cells after intravenous and subcutaneous administration of 1 beta d arabinofuranosylcytosine

Morton D.J., 1984: Pharmacokinetics of 12 anticonvulsant drugs in the rat

Belkien L.; Schurmeyer T.; Hano R.; Gunnarsson P.O.; Nieschlag E., 1985: Pharmacokinetics of 19 nortestosterone esters in normal men

Malik J.K.; Srivastava A.K., 1986: Pharmacokinetics of 2 3 butanedione monoxime in bubalus bubalis after intravenous administration

Geiger, J. D.; Lewis, J. L.; Macintyre, C. J.; Nagy, J. I., 1987: Pharmacokinetics of 2' deoxycoformycin an inhibitor of adenosine deaminase in the rat

Davis R.L.; Koup J.R.; Williams Warren J.; Weber A.; Smith A.L., 1985: Pharmacokinetics of 3 oral formulations of ciprofloxacin

Frey B.M.; Seeberger M.; Frey F.J., 1985: Pharmacokinetics of 3 prednisolone prodrugs evidence of therapeutic inequivalence in renal transplant patients with rejection

Neidlein, R.; Deigner, H. P., 1988: Pharmacokinetics of 4 oxa 5 exo n methylcarbamoyloxytricyclo 5.2.1.02 6e n d o dec 8 en 3one in the rat

Formelli, F.; Carsana, R.; Pollini, C., 1987: Pharmacokinetics of 4' deoxy 4' iododoxorubicin in plasma and tissues of tumor bearing mice compared with doxorubicin

Wile A.G.; Stemmer E.A.; Andrews P.A.; Murphy M.P.; Abramson I.S.; Howell S.B., 1985: Pharmacokinetics of 5 fluorouracil during hyperthermic pelvic isolation perfusion

Didolkar M.S.; Covell D.G.; Jackson A.J.; Walker A.P.; Kalidindi S.R., 1984: Pharmacokinetics of 5 fluorouracil following different routes of intrahepatic administration in the canine model

Kar R.; Cohen R.A.; Terem T.M.; Nahabedian M.Y.; Wile A.G., 1986: Pharmacokinetics of 5 fluorouracil in rabbits in experimental regional chemotherapy

Zanette M.L.; Tirelli U.; Sorio R.; Zadro D.; Figoli F.; Monfardini S.; D'incalci M., 1987: Pharmacokinetics of 7 con o methylnogarol in patients with solid tumors

Slordal L.; Jaeger R.; Kjaeve J.; Aarbakke J., 1988: Pharmacokinetics of 7 hydroxymethotrexate and methotrexate in the rat

Monbaliu J.G.; Belpaire F.M.; Braeckman R.A.; Bogaert M.G., 1988: Pharmacokinetics of 8 methoxypsoralen in the dog

Bernareggi A.; Danese A.; Cavenaghi L. , 1988: Pharmacokinetics of a 40926 in rats after single intravenous and subcutaneous doses

Simmons S.T.; Sherwood M.B.; Nichols D.A.; Penne R.B.; Sery T.; Spaeth G.L., 1988: Pharmacokinetics of a 5 fluorouracil liposomal delivery system

Coppi G.; Mosconi P.; Springolo V., 1987: Pharmacokinetics of a fixed combination of atenolol and indapamide in dogs and humans after oral administration

Del Pozo E.; Schlueter K.; Nueesch E.; Rosenthaler J.; Kerp L., 1986: Pharmacokinetics of a long acting bromocriptine preparation parlodel la and its effects on release of prolactin and growth hormone

Sanders P.; Guillot P.; Mourot D., 1988: Pharmacokinetics of a long acting chloramphenicol formulation administered by intramuscular and subcutaneous routes in cattle

Teare J.A.; Schwark W.S.; Shin S.J.; Graham D.J., 1985: Pharmacokinetics of a long acting oxytetracycline preparation in ring necked pheasants phasianus colchicus great horned owls bubo virginianus and amazon parrots

Longo G.; Matucci M.; Messori A.; Morfini M.; Rossi Ferrini P., 1986: Pharmacokinetics of a new heat treated concentrate of factor viii estimated by model independent methods

Dixon R.; Hsiao J.; Caldwell W., 1988: Pharmacokinetics of a new inotropic catecholamine in dog plasma using solid phase extraction technology

Bedeschi G.; Beltrame M.; Baldin C.; Confente G.; Guerra L.; Fostini R., 1988: Pharmacokinetics of a new oral antibacterial agent ofloxacin in dentistry and oral surgery

Kusajima H.; Ishikawa N.; Machida M.; Uchida H.; Irikura T., 1986: Pharmacokinetics of a new quinolone am 833 in mice rats rabbits dogs and monkeys

Rafikov R.Z.; Tashev M.Sh; Tippaev T.; Khodzhaev S.G.; Aliev Kh U.; Sakhibov A.D., 1987: Pharmacokinetics of a polymer metal complex ii

Gombar C.T.; Demarinis R.M.; Wise M.; Mico B.A., 1988: Pharmacokinetics of a series of 6 chloro 2 3 4 5 tetrahydro 3 substituted 1h 3 benzazepines in rats determination of quantitative structure pharmacokinetic relationships

Anderson E.L.; Van Voris L.P.; Bartram J.; Hoffman H.E.; Belshe R.B., 1987: Pharmacokinetics of a single dose of rimantadine in young adults and children

Nawishy S.; Moukhtar I.; Sabbour M., 1986: Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure

Konovalova N.P.; Diatchkovskaya R.F.; Kukushkina G.V.; Volkova L.M.; Varfolomeev V.N.; Dombrovsky L.S.; Shapiro A.B., 1988: Pharmacokinetics of a spin labeled rubomycin analog

Flouvat B.; Delhotal B.; Kahn J.C.; Crouzette J.; Dubourg O.; Roux A.; Fodor F.; Bourdarias J.P., 1984: Pharmacokinetics of a sustained release hydroquinidine in man single and multiple dose study

Pokrajac M.; Agbaba D.; Pesic V.; Varagic V.M., 1987: Pharmacokinetics of a sustained release preparation of theophylline in asthmatic children

Bruguerolle B.; Barbeau G.; Belanger P.M.; Labrecque G., 1986: Pharmacokinetics of a sustained release product of indomethacin in the elderly

Isles A.F.; Newth C.J.L., 1985: Pharmacokinetics of a sustained release theophylline preparation in infants and preschool children with asthma

Schaad U.B.; Casey P.A.; Ravenscroft A.T., 1986: Pharmacokinetics of a syrup formulation of amoxycillin potassium clavulanate in children

Arboix M.; Rey E.; Clos F.; Camarasa J., 1985: Pharmacokinetics of acenocoumarol in patients with bjork valvular prosthesis

Putcha L.; Griffith D.P.; Feldman S., 1985: Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi

Li Z R.; Luo S R.; Han R.; Rong Z Y.; Liao Q F.; Chen R X., 1987: Pharmacokinetics of aclacinomycin a in normal rats and mice bearing sarcoma 180 s 180

Ando S.; Nakamura T.; Kagawa D.; Ueda T.; Nishimura T.; Kubo A.; Tsutani H.; Sasada M.; Uchino H., 1986: Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells

Jordan J.C.; Klatt P.; Ludwig B., 1987: Pharmacokinetics of aditoprim a new long acting dihydrofolate reductase inhibitor in heifers

Preiss R.; Matthias M.; Sohr R.; Brockmann B.; Hueller H., 1987: Pharmacokinetics of adriamycin adriamycinol and antipyrine in patients with moderate tumor involvement of the liver

Schulte, H. M.; Moenig, H.; Benker, G.; Pagel, H.; Reinwein, D.; Ohnhaus, E. E., 1987: Pharmacokinetics of aldosterone in patients with addison's disease effect of rifampicin treatment on glucocorticoid and mineralocorticoid metabolism

Roure P.; Jean N.; Leclerc A C.; Cabanel N.; Levron J C.; Duvaldestin P., 1987: Pharmacokinetics of alfentanil in children undergoing surgery

Chauvin M.; Lebrault C.; Levron J.C.; Duvaldestin P., 1987: Pharmacokinetics of alfentanil in chronic renal failure

Persson M.P.; Nilsson A.; Hartvig P., 1988: Pharmacokinetics of alfentanil in total iv anesthesia

Paillet M.; Merdjan H.; Doucet D., 1986: Pharmacokinetics of alminoprofen in healthy subjects influence of the time of administration

Kuhn J.G.; Balmer C.E.; Ludden T.M.; Loesch D.M.; Von Hoff D.D.; Bender J.F.; Grillo Lopez A.J., 1987: Pharmacokinetics of ametantrone acetate nsc 287513

Vincon G.; Sanchez R.; Perro G.; Cutillas M.; Castede J.C.; Masse C.; Albin H., 1986: Pharmacokinetics of amikacin in burn patients

Motohiro T.; Tanaka K.; Kawakami A.; Koga T.; Shimada Y.; Tomita S.; Sakata Y.; Fujimoto T.; Nishiyama T.; Et Al, 1987: Pharmacokinetics of amikacin in children and neonates

Vincent P.; Izard D.; Colombel J.F.; Husson M.O.; Cortot A.; Paris J.C.; Leclerc H., 1985: Pharmacokinetics of amikacin in cirrhotic patients with ascites

Autret E.; Marchand S.; Breteau M.; Grenier B., 1986: Pharmacokinetics of amikacin in cystic fibrosis a study of bronchial diffusion

Takimoto M.; Yano K.; Fujita K.; Yoshioka H.; Sanae N.; Maruyama S., 1987: Pharmacokinetics of amikacin in infants and children

Yura J.; Hayashi S.; Tsuruga N.; Hashimoto T.; Murata Y.; Kamiya Y., 1987: Pharmacokinetics of amikacin in the pediatric surgical field

Dolgova G.V.; Berezhinskaya V.V.; Firsov A.A., 1986: Pharmacokinetics of amikacin in the perilymph and blood serum an approach to a comparative estimation of potential ototoxicity of aminoglycoside antibiotics

Spahn H.; Reuter K.; Mutschler E.; Gerok W.; Knauf H., 1987: Pharmacokinetics of amiloride in renal and hepatic disease

Cadorniga R.; Pastoriza P.; Saiz Vadillo M.C.; Molina I.T.; Prats D.; Torrente J.; Barrientos A., 1986: Pharmacokinetics of aminoglycoside antibiotics in patients with renal failure undergoing hemofiltration 1

Cadorniga R.; Pastoriza P.; Saiz Vadillo M.C.; Molina I.T.; Prats D.; Torrente J.; Barrientos A., 1986: Pharmacokinetics of aminoglycoside antibiotics in patients with renal failure undergoing hemofiltration ii

Staubli M.; Troendle A.; Schmid B.; Balmer P.; Kohler B.; Studer H.; Bircher J., 1985: Pharmacokinetics of amiodarone deethylamiodarone and other iodine containing amiodarone metabolites

Karkkainen S.; Neuvonen P.J., 1986: Pharmacokinetics of amitriptyline influenced by oral charcoal and urine ph

Lu K.; Mclean M.A.; Vestal M.L.; Newman R.A., 1988: Pharmacokinetics of amonafide in dogs

Kamimura H.; Sasaki H.; Kawamura S., 1984: Pharmacokinetics of amosulalol an alpha beta adrenoceptor blocker in rats dogs and monkeys

Calvo B.; Garcia M.J.; Pedraz J.L.; Marino E.L.; Dominguez Gil A., 1985: Pharmacokinetics of amoxapine and its active metabolites

Drumev D.; Kojchev K.; Lashev L.; Borisov I., 1985: Pharmacokinetics of amoxicillin trihydrate in sheep experimentally infected with escherichia coli and corynebacterium pyogenes

Ksiazek A.; Twardowski Z.; Przyborowski L.; Majdan M.; Sokolowska G.; Hopkala H.; Solski J.; Zbikowska A.; Misztal G.; Et Al, 1983: Pharmacokinetics of amoxycillin and ampicillin in patients with renal failure

Starke J.R.; Mason E.O.Jr; Kramer W.G.; Kaplan S.L., 1987: Pharmacokinetics of amphotericin b in infants and children

Khanikor H.N.; Srivastava A.K.; Paul B.S.; Malik J.K., 1986: Pharmacokinetics of ampicillin and amoxycillin in bubalus bubalis following intramuscular administration

Yakovlev V.P.; Skala L.Z.; Chernyakov V.L.; Shcherbakov V.A.; Shuster A.M.; Nekhorosheva A.G.; Shabalova L.A.; Vetchinnikova O.N.; Sirota L.A., 1985: Pharmacokinetics of ampicillin in patients with chronic renal insufficiency under hemodialysis and hemosorption

Akhtamova Z.M.; Kholodov L.E.; Dorokhov V.V.; Gurtovoi B.L., 1985: Pharmacokinetics of ampicillin in pregnant women with acute pyelonephritis

Zhang G M.; Jin B Q., 1986: Pharmacokinetics of amygdalin in rabbits

Terauchi Y.; Watari S.; Ishikawa S.; Takeyama K.; Sekine Y.; Hashimoto M.; Hayashi T., 1988: Pharmacokinetics of an active cadralazine metabolite in plasma and blood vessels of spontaneously hypertensive rats

Astier A.; Petitjean O., 1985: Pharmacokinetics of an anticholinesterasic agent eserine n oxide in humans after administration of two galenic forms

Ostrowski J.; Gaul G.; Voegele D.; Brockmeier D.; Resag K., 1985: Pharmacokinetics of an extended release dosage form of molsidomine in patients with coronary heart disease

Hnatowich D.J.; Griffin T.W.; Kosciuczyk C.; Rusckowski M.; Childs R.L.; Mattis J.A.; Shealy D.; Doherty P.W., 1985: Pharmacokinetics of an indium 111 labeled monoclonal antibody in cancer patients

Pendyala L.; Creaven P.J.; Huben R.; Tremblay D.; Bertagna C., 1988: Pharmacokinetics of anandron in patients with advanced carcinoma of the prostate

Villegas Navarro A.; Martinez Morales M.; Morales Aguilera A., 1986: Pharmacokinetics of anthracene 9 carboxylic acid a potent myotonia inducer

Seifried E.; Tanswell P.; Rijken D.C.; Barrett Bergshoeff M.M.; Su C.A.P.F.; Kluft C., 1988: Pharmacokinetics of antigen and activity of recombinant tissue type plasminogen activator after infusion in healthy volunteers

Lur'e, A. A.; Ovusu, A.; Petrov, O. E.; Ozeretskovskaya, N. N., 1985: Pharmacokinetics of antionchocerciasis drugs 2. pharmacokinetics of suramin when administered simultaneously with diethylcarbamazine

Engelking L.R.; Blyden G.T.; Lofstedt J.; Greenblatt D.J., 1987: Pharmacokinetics of antipyrine acetaminophen and lidocaine in fed and fasted horses

Rimmer E.M.; Routledge P.A.; Tsanaclis L.M.; Richens A., 1986: Pharmacokinetics of antipyrine in epileptic patients

Israili Z.H.; Rogers C.M.; El Attar H., 1987: Pharmacokinetics of antituberculosis drugs in patients

Vereczkey L.; Pudleiner P., 1987: Pharmacokinetics of apovincaminic acid in dogs

Tomono, N.; Sannomiya, F.; Nakayoshi, T.; Shinkai, S.; Fujita, M., 1987: Pharmacokinetics of arbekacin in dogs i. serum concentration and urinary excretion

Tomono, N.; Nakayoshi, T.; Shinkai, S.; Fujita, M., 1987: Pharmacokinetics of arbekacin in dogs ii. the distribution of arbekacin in tissues

Garg S.K.; Kumar B.; Shukla V.K.; Bakaya V.; Lal R.; Kaur S., 1988: Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dapsone therapy

Higgs G.A.; Salmon J.A.; Henderson B.; Vane J.R., 1987: Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity

Moriguchi R.; Yamagoshi T.; Nemoto S.; Naide Y.; Suzuki K.; Inoue A.; Kobayashi S., 1986: Pharmacokinetics of astromicin intravenous drip infusion to patients with renal disorders

Spahn H.; Langguth P.; Krauss D.; Kirch W.; Mutschler E., 1987: Pharmacokinetics of atenolol and metoprolol administered together with piroxicam

Ward S.; Boheimer N.; Weatherley B.C.; Simmonds R.J.; Dopson T.A., 1987: Pharmacokinetics of atracurium and its metabolites in patients with normal renal function and in patients in renal failure

Brandom B.W.; Stiller R.L.; Cook D.R.; Woelfel S.K.; Chakravorti S.; Lai A., 1986: Pharmacokinetics of atracurium in anesthetized infants and children

Pihlajamaki K.; Kanto J.; Aaltonen L.; IIsalo E.; Jaakkola P., 1986: Pharmacokinetics of atropine in children

Michalsen H.; Bergan T., 1986: Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases

Creasey W.A.; Platt T.B.; Frantz M.; Sugerman A.A., 1985: Pharmacokinetics of aztreonam in elderly male volunteers

Mattie H.; Matze Van Der Lans A., 1986: Pharmacokinetics of aztreonam in infected patients

Fillastre J.P.; Leroy A.; Baudoin C.; Humbert G.; Swabb E.A.; Vertucci C.; Godin M., 1985: Pharmacokinetics of aztreonam in patients with chronic renal failure

Miyakawa I.; Taniyama K.; Nagai K.; Yamao H.; Sendai M.V.; Kawano K.; Mori N., 1985: Pharmacokinetics of aztreonam in peripheral venous serum uterine arterial serum and intrapelvic female organs

Haroche G.; Salvanet A.; Lafaix C.; Dubayle P.; Forestier F.; Meulmans A.; Lang T., 1986: Pharmacokinetics of aztreonam in the aqueous humor

Ripa S.; Ferrante L.; Mignini F.; Ecari U.; Ruffilli M.P., 1988: Pharmacokinetics of bacampicillin using a compartment model with zero order absorption

Larionova N.I.; Kazanskaya N.F.; Mityushina G.V.; Blidchenko Yu A.; Vladimirov V.G., 1984: Pharmacokinetics of basic polyvalent protease inhibitor bound with dextran carboxymethyl ester

Preiss R.; Sohr R.; Matthias M.; Brockmann B.; Hueller H., 1985: Pharmacokinetics of bendamustin cytostasan in patients

Rovei V.; Campistron G.; Dueymes J M.; Ego D.; Conte J.J.; Houin G., 1987: Pharmacokinetics of bendazac lysine and 5 hydroxybendazac in patients with renal insufficiency

Furlanut M.; Benetello P.; Perosa A.; Colombo G.; Gallo F.; Forgione A., 1988: Pharmacokinetics of benperidol in volunteers after oral administration

Chasseaud L.F.; Catanese B., 1985: Pharmacokinetics of benzydamine

Bobrov V.I.; Olevskii I.Kh; Segel'man V.S.; Yakovlev V.P., 1987: Pharmacokinetics of benzylpenicillin and ampicillin in patients after their use in combination with sulfalen and sulfadimethoxine

Skala L.Z.; Abramyan R.G.; Shanina A.G.; Razgarova N.K.; Nekhorosheva A.G., 1987: Pharmacokinetics of benzylpenicillin and gentamicin after administration by various routes to patients with acute and chronic nonspecific diseases of the lungs

Esteve J.; Martinez L.; Roser R.; Sagarra R., 1987: Pharmacokinetics of besulpamide in rats and dogs

Bianchetti, G.; Thiercelin, J. F.; Thenot, J. P., 1986: Pharmacokinetics of betaxolol in middle aged patients

Mohan P.K.; Reddy L.V.; Sriram K.I., 1987: Pharmacokinetics of bevidox in functionally different muscles of albino rat during prolonged intense activity

Boyer A.W.; Somani S.M., 1985: Pharmacokinetics of biliary excretion of physostigmine in rat

Jorgensen K.D.; Monrad J.D.; Brondum L.; Dinesen B., 1988: Pharmacokinetics of biosynthetic and pituitary human growth hormones in rats

Kirch W.; Rose I.; Demers H.G.; Leopold G.; Pabst J.; Ohnhasu E.E., 1987: Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease

Smolyanskaya A.Z.; Spitsyna T.A.; Manzyuk L.V., 1984: Pharmacokinetics of bleomycetin an antitumor antibiotic in oncological patients treated with the drug using various methods of administration

Harper P.; Elwin C E.; Cederblad G., 1988: Pharmacokinetics of bolus intravenous and oral doses of l carnitine in healthy subjects

Kalager T.; Digranes A.; Salveson A.; Bergan T., 1985: Pharmacokinetics of brodimoprim in serum and skin blister fluid

Hilderbrand M.; Huempel M.; Krause W.; Taeuber U., 1987: Pharmacokinetics of bromerguride a new dopamine antagonistic ergot derivative in rat and dog

Zin'kovskii V.G.; Vasilinin G.B.; Stankevich E.O.; Golovenko N.Ya; Zhuk O.V., 1988: Pharmacokinetics of bromonordiazepam after the single administration and various protocols of the prolonged administration of the preparation and its carbon 14 labeled analog

Pedersen S.; Steffensen G.; Ekman I.; Tonnesson M.; Borga O., 1987: Pharmacokinetics of budesonide in children with asthma

Rey E.; D'athis R.; Richard M.O.; Fillastre J.P.; Olive G., 1984: Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure

Holazo A.A.; Colburn W.A.; Gustafson J.H.; Young R.L.; Parsonnet M., 1984: Pharmacokinetics of bumetanide following intravenous intramuscular and oral administrations to normal subjects

Freysz M.; Beal J.L.; D'athis P.; Mounie J.; Wilkening M.; Escousse A., 1987: Pharmacokinetics of bupivacaine after axillary brachial plexus block

Mazoit J.X.; Denson D.D.; Samii K., 1988: Pharmacokinetics of bupivacaine following caudal anesthesia in infants

Suckow R.F.; Smith T.M.; Perumal A.S.; Cooper T.B., 1986: Pharmacokinetics of bupropion and metabolites in plasma and brain of rats mice and guinea pigs

Sethy V.; Francis J.W., 1988: Pharmacokinetics of buspirone as determined by ex vivo tritiated dpat binding

Houin G.; Barre J.; Jeanniot J.P.; Ledudal P.; Cautreels W.; Tillement J.P., 1984: Pharmacokinetics of butofilolol cafide after repeated oral administration in man

Arranz M.A.; Perez M.I.; Saiz Vadillo M.C.; Basagoiti I.; Katarneh S.M.; Ribas B.; Cadorniga R., 1984: Pharmacokinetics of cadmium 109 in blood and cerebral structures of the rat

Nakazawa K.; Tanaka H., 1988: Pharmacokinetics of caffeine and dimethylxanthines in plasma and saliva

Stavchansky S.; Combs A.; Sagraves R.; Delgado M.; Joshi A., 1988: Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers

Plessas C.T.; Karayannakos P.; Plessas S.T.; Costakis A.; Donta I.; Skalkeas G., 1986: Pharmacokinetics of calcium dobesilate in beagle dogs after a single administration

Plessas C.T.; Karayannakos P.; Plessas S.T.; Costakis A.; Donta I.; Skalkeas G., 1986: Pharmacokinetics of calcium dobesilate in beagle dogs after repeated administration

Osterloh J.; Becker C.E., 1986: Pharmacokinetics of calcium sodium edta and chelation of lead in renal failure

Samara E.; Bialer M.; Mechoulam R., 1988: Pharmacokinetics of cannabidiol in dogs

Ho P.C.; Bourne D.W.A.; Triggs E.J.; Heazlewood V., 1984: Pharmacokinetics of canrenone and metabolites after base hydrolysis following single and multiple dose oral administration of spironolactone

Creasey W.A.; Funke P.T.; Mckinstry D.N.; Sugerman A.A., 1986: Pharmacokinetics of captopril in elderly healthy male volunteers

Bezek S.; Faberova V.; Scasnar V.; Trnovec T.; Durisova M.; Kallay Z., 1988: Pharmacokinetics of carbisocaine in rats and mice

Segre G.; Bianchi E.; Cecchettin M.; Conte N.; Manente P., 1986: Pharmacokinetics of carbocalcitonin in humans

Sako K.; Diksic M.; Farrokhzad S.; Yamamoto Y.L.; Feindel W., 1985: Pharmacokinetics of carbon 11 labeled 1 3 bis 2 chloroethyl 1 nitrosourea in experimental brain tumor

Amlacher R.; Kuehnel H J.; Niemann G.; Schulze W.; Hoffmann H., 1987: Pharmacokinetics of carbon 14 ambazone in small laboratory animals

Vinge E.; Midskov C.; Arnold E., 1986: Pharmacokinetics of carbon 14 fenflumizole after intravenous administration to man

Colburn W.A.; Vane F.M.; Bugge C.J.L.; Carter D.E.; Bressler R.; Ehmann C.W., 1985: Pharmacokinetics of carbon 14 isotretinoin in healthy volunteers and volunteers with biliary t tube drainage

Kassem M.A.; Schulte K.E., 1984: Pharmacokinetics of carbon 14 labeled mofebutazone after oral administration in man

Naesdal J.; Andersson T.; Bodemar G.; Larsson R.; Regardh C G.; Skanberg I.; Walan A., 1986: Pharmacokinetics of carbon 14 omeprazole in patients with impaired renal function

Bernareggi A.; Cavenaghi L.; Assandri A., 1986: Pharmacokinetics of carbon 14 teicoplanin in male rats after single intravenous dose

Elferink F.; Van Der Vijgh W.J.F.; Klein I.; Ten Bokkel Huinink W.W.; Dubbelman R.; Mcvie J.G., 1988: Pharmacokinetics of carboplatin after intraperitoneal administration

Weenen, H.; Pinedo, H. M.; De-Planque, M. M.; Ten-Bokkel-Huinink, W. W.; Mcvie, J. G.; Lankelma, J., 1984: Pharmacokinetics of carminomycin in man biweekly schedule vs. single dose every 3 weeks

Hasenfuss G.; Schaefer Korting M.; Knauf H.; Mutschler E.; Just H., 1985: Pharmacokinetics of carteolol in relation to renal function

Berube D.; Vallee F.; Panneton A C.; Bergeron M.G.; Lebel M., 1988: Pharmacokinetics of carumonam after single and multiple 1 g and 2 g dosage regimens

Horber F.; Egger H J.; Weidekamm E.; Dubach U.C.; Frey F.J.; Probst P.J., 1986: Pharmacokinetics of carumonam in patients with renal insufficiency

Okano M.; Komeda H.; Akino H.; Isomatsu Y.; Muranaka K.; Kanimoto Y.; Shimizu Y.; Kawada Y., 1987: Pharmacokinetics of cddp with sts and its effects on renal function

Mastrandrea V.; Ripa S.; La Rosa F.; Ghezzi A., 1985: Pharmacokinetics of cefatrizine after oral administration in human volunteers

Lanao J.M.; Vicente M.T.; Dominguez Gil A., 1988: Pharmacokinetics of cefazolin administered as a new drug delivery system in healthy volunteers

Fritz P.E.; Hurst W.J.; White W.J.; Lang C.M., 1987: Pharmacokinetics of cefazolin in guinea pigs

Firsov A.A.; Treskina O.S.; Nasonov V.N.; Umnova L.V.; Chernyakov V.L.; Vetchinnikova O.N., 1986: Pharmacokinetics of cefazolin in hemoperfusion and hemodialysis

Koup J.R.; Dubach U.C.; Brandt R.; Wyss R.; Stoeckel K., 1988: Pharmacokinetics of cefetamet ro 15 8074 and cefetamet pivoxil ro 15 8075 after intravenous and oral doses in humans

Faulkner R.D.; Bohaychuk W.; Desjardins R.E.; Look Z.M.; Haynes J.D.; Weiss A.I.; Silber B.M., 1987: Pharmacokinetics of cefixime after once a day and twice a day dosing to steady state

Bialer M.; Wu W.H.; Look Z.M.; Silber B.M.; Yacobi A., 1987: Pharmacokinetics of cefixime after oral and intravenous doses in dogs bioavailability assessment for a drug showing nonlinear serum protein binding

Guay D.R.P.; Meatherall R.C.; Harding G.K.; Brown G.R., 1986: Pharmacokinetics of cefixime cl 284635 fk 027 in healthy subjects and patients with renal insufficiency

Maeda H.; Sako M.; Fujii A.; Yamazaki H.; Kawabata G.; Harada M.; Arakawa S.; Umezu K.; Kamidono S.; Et Al, 1986: Pharmacokinetics of cefixime in patients with impaired renal function

Faulkner R.D.; Bohaychuk W.; Lanc R.A.; Haynes J.D.; Desjardins R.E.; Yacobi A.; Silber B.M., 1988: Pharmacokinetics of cefixime in the young and elderly

Veyssier P.; Bryskier A.; Modai J.; Boquet A.; Fourtillan J.B., 1986: Pharmacokinetics of cefmenoxime in elderly patients 60 to 90 years old after 1 g iv bolus

Konishi K., 1986: Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis

Hasegawa H.; Itagaki N.; Tsujino M.; Takahashi K.; Yamamoto Y.; Imada A.; Horiuchi A., 1988: Pharmacokinetics of cefmenoxime in renal failure patients undergoing continuous arteriovenous hemofiltration

Rodriguez Barbero J.; Marino E.L.; Dominguez Gil A., 1985: Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults

Rodriguez Barbero J.; Marino E.L.; Barrueco M.; Dominguez Gil A., 1984: Pharmacokinetics of cefmetazole and cefoxitin following their simultaneous administration to healthy volunteers

Miura T.; Hashimoto I.; Sawada Y.; Nakamura T.; Nakahara M., 1987: Pharmacokinetics of cefmetazole during and after surgical operation

Heim Duthoy K.L.; Peltier G.L.; Guay D.R.P.; Matzke G.R., 1988: Pharmacokinetics of cefonicid in patients with skin and skin structure infections

Fillastre J P.; Fourtillan J B.; Leroy A.; Ramis N.; Lefevre M A.; Reumont G.; Humbert G., 1986: Pharmacokinetics of cefonicid in uremic patients

Reitberg, D. P.; Marble, D. A.; Schultz, R. W.; Whall, T. J.; Schentag, J. J., 1988: Pharmacokinetics of cefoperazone 2.0 g and sulbactam 1.0 g coadministered to subjects with normal renal function patients with decreased renal function and patients with end stage renal disease on hemodialysis

Ripa S.; La Rosa F.; Dainelli B.; Ecari U.; Ruffilli M.P., 1986: Pharmacokinetics of cefoperazone after single and multiple doses

Guglielmo B.J.; Flaherty J.F.; Woods T.M.; Lafollette G.; Gambertoglio J.G., 1987: Pharmacokinetics of cefoperazone and tobramycin alone and in combination

Monden Y.; Fujimoto Y.; Nakahara K., 1986: Pharmacokinetics of cefoperazone concentration in human lung tissue

Meyers B.R.; Mendelson M.H.; Deeter R.G.; Srulevitch Chin E.; Sarni M.T.; Hirschman S.Z., 1987: Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults

Okuda T.; Katoh T.; Takaichi K.; Matsunaga H.; Uchida S.; Kurokawa K., 1986: Pharmacokinetics of cefoperazone in end stage renal failure patients on peritoneal dialysis

Kakiuchi S.; Tagawa S.; Tameda Y.; Kosaka Y., 1985: Pharmacokinetics of cefoperazone in liver diseases

Philips J.B.IIi; Braune K.; Ravis W.; Cassady G.; Dillon H., 1984: Pharmacokinetics of cefoperazone in newborn infants

Gonik B.; Feldman S.; Pickering L.K.; Doughtie C.G., 1986: Pharmacokinetics of cefoperazone in the parturient

Guerrini V.H.; Filippich L.J.; Cao G.R.; English P.B.; Borne D.W.A., 1985: Pharmacokinetics of ceforanide ceftriaxone and cefoperazone in sheep

Moukhtar I.; Nawishy S.; Sabbour M., 1987: Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function

Beyssac E.; Cardot J M.; Colnet G.; Sirot J.; Aiache J M., 1987: Pharmacokinetics of cefotaxime and its desacetyl metabolite in plasma and in cerebrospinal fluid

Wang W L.; Wu X Z.; Li T Y.; Xu X Y.; Li J T., 1986: Pharmacokinetics of cefotaxime in normal subjects

Charles D.; Larsen B., 1986: Pharmacokinetics of cefotaxime moxalactam and cefoperazone in the early puerperium

Ripa S.; Mignini F.; Prenna M., 1987: Pharmacokinetics of cefotetan in elderly subjects after intramuscular administration

Browning M.J.; Holt H.A.; White L.O.; Chapman S.T.; Banks R.A.; Reeves D.S.; Yates R.A., 1986: Pharmacokinetics of cefotetan in patients with end stage renal failure on maintenance dialysis

Brisson A M.; Bryskier A.; Millerioux L.; Fourtillan J B., 1984: Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults

Lecaillon J.B.; Rouan M.C.; Binswanger U.; Guibert J.; Schoeller J.P., 1984: Pharmacokinetics of cefotiam and cefsulodin after simultaneous administration to patients with impaired renal function

Alonso I.G.; Marino E.L.; Dominguez Gil A.; Tabernero J.M., 1986: Pharmacokinetics of cefotiam during hemofiltration

Itagaki N.; Hasegawa H.; Tsujino M.; Takahashi K.; Yamamoto Y.; Imada A.; Horiuchi A., 1988: Pharmacokinetics of cefotiam in patients undergoing continuous ambulatory peritoneal dialysis

Konishi K.; Ozawa Y., 1984: Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis

Mizuta E.; Kaneko Y.; Nishindai H.; Yoshimoto M.; Nakanishi Y.; Hashimoto I.; Sawada Y.; Nakamura T.; Mikami J., 1986: Pharmacokinetics of cefotiam in the exudate from wounds of patients with breast cancer operated upon for radical mastectomy

Lakings D.B.; Friis J.M.; Brown R.J.; Allen H.R., 1984: Pharmacokinetics of cefpimizole in normal humans after single dose and multiple dose intravenous infusions

Ikeda T.; Sakai T.; Nishimura Y., 1987: Pharmacokinetics of cefpiramide concentration in lung tissues

Conte J.E.Jr, 1987: Pharmacokinetics of cefpiramide in volunteers with normal or impaired renal function

Maass L.; Malerczyk V.; Verho M., 1987: Pharmacokinetics of cefpirome hr 810 a new cephalosporin derivative administered intramuscularly and intravenously to healthy volunteers

Drusano G.L.; Joshi J.; Forrest A.; Ruxer R.; Standiford H.; Leslie J.; Wade J.; Schimpff S., 1985: Pharmacokinetics of ceftazidime alone or in combination with piperacillin or tobramycin in the sera of cancer patients

Ganzinger U.; Kleinberger G.; Lenz K.; Schatz F.; Laggner A.; Grimm G., 1987: Pharmacokinetics of ceftazidime and netilmicin in patients with sepsis

Lebel M.; Barbeau G.; Vallee F.; Bergeron M.G., 1985: Pharmacokinetics of ceftazidime in elderly volunteers

Walstad R.A.; Wiig J.N.; Thurmann Nielsen E.; Halvorsen T.B., 1986: Pharmacokinetics of ceftazidime in patients with biliary tract disease

Ohkawa M.; Nakashima T.; Shoda R.; Ikeda A.; Orito M.; Sawaki M.; Sugata T.; Shimamura M.; Hirano S.; Okumura K., 1985: Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis

Prinsloo J.G.; Delport S.D.; Moncrieff J.; Paton A.M., 1984: Pharmacokinetics of ceftazidime in premature newborn and young infants

Gundert Remy U.; Hildebrandt R.; Stiehl A.; Schlegel P., 1985: Pharmacokinetics of ceftizoxime

Nishimura K I.; Nozaki Y.; Yoshimi A.; Nakamura S.; Kitagawa M.; Kitagawa M.; Oketani T.; Nishimura M.; Kakeya N., 1985: Pharmacokinetics of ceftizoxime suppository in experimental animals

Regamey C., 1985: Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments comparison with cefotaxime

Martin E.; Koup J.R.; Paravicini U.; Stoeckel K., 1984: Pharmacokinetics of ceftriaxone in neonates and infants with meningitis

Xiang X.; Wang Q N.; Liu Y H.; Jiang Y F., 1987: Pharmacokinetics of ceftriaxone in normal chinese

Miyakawa I.; Taniyama K.; Nagai K.; Yasuda H.; Mori N., 1984: Pharmacokinetics of ceftriaxone in peripheral venous serum uterine arterial serum and intrapelvic genital organs

De Grandi P.; Bauen J F., 1986: Pharmacokinetics of ceftriaxone in serum and gynecological tissues

Kowalsky S.F.; Echols R.M.; Parker M.A., 1985: Pharmacokinetics of ceftriaxone in subjects with renal insufficiency

Akhtamova Z.M.; Kholodov L.E.; Dorokhov V.V.; Voropaeva S.D., 1985: Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis

Miyakawa I.; Yamao H.; Taniyama K.; Kawano K.; Haruyama Y.; Mori N., 1987: Pharmacokinetics of cefuzonam in peripheral venous serum uterine arterial serum and intrapelvic female organs

Agarwal N.; Sharma S.; Srivastava V.M.L., 1988: Pharmacokinetics of centperazine a new antifilarial agent

Silley P.; Rudd A.P.; Symington W.M.; Tait A.J., 1988: Pharmacokinetics of cephalexin in dogs and cats after oral subcutaneous and intramuscular administration

Bobrov V.I.; Beletskaya G.T.; Yakovlev V.P., 1984: Pharmacokinetics of cephaloridine and cephalothin combinations with sulfalene in rabbits

Ganzinger U.; Haslberger A., 1985: Pharmacokinetics of cephalosporins in normal and septicemic rabbits

Balogh A.; Peiker G.; Meinhold P.; Traeger A., 1985: Pharmacokinetics of cephalothin after single and repeated administration in man

Agapitova I.V.; Yakovlev V.P., 1987: Pharmacokinetics of certain antibiotics in rats with infected inflammation

Skoutakis V.A.; Acchiardo S.A.; Carter C.A.; Ingebretsen C.G.; Klausner M.A.; Lee D.K.H.; Kraml M., 1988: Pharmacokinetics of cetamolol in hypertensive patients with normal and compromised renal function

Buur T.; Larsson R.; Norlander B., 1988: Pharmacokinetics of chloral hydrate poisoning treated with hemodialysis and hemoperfusion

Guillot P.; Sanders P.; Mourot D., 1988: Pharmacokinetics of chloramphenicol in rabbits

Bareggi S.R.; Pirola R.; Leva S.; Zecca L., 1986: Pharmacokinetics of chlorodemethyldiazepam after single dose oral administration in humans

Neuvonen P.J.; Karkkainen S.; Lehtovaara R., 1987: Pharmacokinetics of chloropropamide in epileptic patients effects of enzyme induction and urine ph on chlorpropamide elimination

Edwards G.; Looaressuwan S.; Davies A.J.; Wattanagoon Y.; Phillips R.E.; Warrell D.A., 1988: Pharmacokinetics of chloroquine in thais plasma and red cell concentrations following an intravenous infusion to healthy subjects and patients with plasmodium vivax malaria

Ette E.I.; Essien E.E.; Brown Awala E.E., 1986: Pharmacokinetics of chloroquine saliva and plasma levels relationship

Veenendaal J.R.; Edstein M.D.; Rieckmann K.H., 1988: Pharmacokinetics of chlorproguanil in man after a single oral dose of lapudrine

Dyer D.C., 1988: Pharmacokinetics of chlortetracycline in the turkey evaluation of biliary secretion

Richards A.; Kragstrup J.; Nielsen Kudsk F., 1985: Pharmacokinetics of chronic fluoride ingestion in growing pigs

Massarella J.W.; Khoo K C.; Szuna A.J.; Sandor D.A.; Morganroth J.; Aogaichi K., 1986: Pharmacokinetics of cibenzoline after single and repetitive dosing in healthy volunteers

Canal M.; Flouvat B.; Aubert P.; Guedon J.; Prinseau J.; Baglin A., 1985: Pharmacokinetics of cibenzoline in patients with renal impairment

Chin T.W.F.; Spino M.; Macleod S.M.; Mahon W.A.; Soldin S.J., 1986: Pharmacokinetics of cimetidine after subchronic administration

Cherruault Y.; Sarin V.B., 1986: Pharmacokinetics of cimetidine in humans

Gonzalez Martin G.; Arancibia A.; Fajuri M.; Chesta J.; Novoa J., 1985: Pharmacokinetics of cimetidine in patients with liver disease

Braga P.C.; Fraschini F.; Scaglione F.; Scarpazza G.; Schiavi M.; Ventura P., 1987: Pharmacokinetics of cinoxacin in elderly patients following repeated oral administration

Bergan T.; Dalhoff A.; Rohwedder R., 1988: Pharmacokinetics of ciprofloxacin

Siefert H.M.; Maruhn D.; Maul W.; Foerster D.; Ritter W., 1986: Pharmacokinetics of ciprofloxacin 1st communication absorption concentrations in plasma metabolism and excretion after a single administration of carbon 14 ciprofloxacin in albino rats and rhesus monkeys macaca mulatta

Siefert H.M.; Maruhn D.; Scholl H., 1986: Pharmacokinetics of ciprofloxacin 2nd communication distribution to elimination from tissues and organs following single or repeated administration of carbon 14 ciprofloxacin in albino rats

Bergan T.; Thorsteinsson S.B.; Kolstad I.M.; Johnsen S., 1986: Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses

Hoeffken G.; Lode H.; Prinzing C.; Borner K.; Koeppe P., 1985: Pharmacokinetics of ciprofloxacin after oral and parenteral administration

Bergan T.; Delin C.; Johansen S.; Kolstad I.M.; Nord C.E.; Thorsteinsson S.B., 1986: Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

Nouws J.F.M.; Grondel J.L.; Schutte A.R.; Laurensen J., 1988: Pharmacokinetics of ciprofloxacin in carp african catfish and rainbow trout

Davis R.L.; Koup J.R.; Williams Warren J.; Weber A.; Heggen L.; Stempel D.; Smith A.L., 1987: Pharmacokinetics of ciprofloxacin in cystic fibrosis

Borner K.; Hoeffken G.; Lode H.; Koeppe P.; Prinzing C.; Glatzel P.; Wiley R.; Olschewski P.; Sievers B.; Reinitz D., 1986: Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration

Bayer A.; Gajewska A.; Stephens M.; Stark J.M.; Pathy J., 1987: Pharmacokinetics of ciprofloxacin in the elderly

Singlas E.; Taburet A.M.; Landru I.; Albin H.; Ryckelinck J.P., 1987: Pharmacokinetics of ciprofloxacin tablets in renal failure influence of hemodialysis

Bajorin D.F.; Bosl G.J.; Alcock N.W.; Niedzwiecki D.; Gallina E.; Shurgot B., 1986: Pharmacokinetics of cis diamminedichloroplatinum ii after administration in hypertonic saline

Hatae M., 1986: Pharmacokinetics of cisplatinum and sodium thiosulfate of intraperitoneal two channel chemotherapy in man and mongrel dog

Nilsson Ehle I.; Fellner H.; Hedstrom S A.; Nilsson Ehle P.; Sjovall J., 1985: Pharmacokinetics of clavulanic acid given in combination with amoxycillin in volunteers

Nanbo T., 1988: Pharmacokinetics of clearance in the maternal fetal amniotic fluid system of the rat

Bell M.J.; Shackelford P.; Smith R.; Schroeder K., 1984: Pharmacokinetics of clindamycin phosphate in the 1st year of life

Schaad Lanyi Z.; Dieterle W.; Dubois J P.; Theobald W.; Vischer W., 1987: Pharmacokinetics of clofazimine in healthy volunteers

Hartikainen Sorri A L.; Heikkinen J.E.; Koivisto M., 1987: Pharmacokinetics of clonidine during pregnancy and nursing

Legler U.F., 1988: Pharmacokinetics of cloprednol in health volunteers

Zeng Y L.; Wang Z R.; Lu M L., 1986: Pharmacokinetics of clozapine in rabbits

Necciari J.; Mery D.; Garriot P.; Escourrou J.; Cautreels W., 1985: Pharmacokinetics of cm 57755 a new histamine h 2 receptor antagonist after single oral doses in man

Chiandussi L.; Fonzo D.; Franzone J.S.; Springolo V.; Borella F.; Coppi G., 1988: Pharmacokinetics of co tetroxazine in volunteers after rectal administration

Leone N.; Barzaghi N.; Monteleone M.; Perucca E.; Cerutti R.; Crema A., 1987: Pharmacokinetics of co trimazine after single and multiple doses

Bergan T.; Allgulander S.; Fellner H., 1986: Pharmacokinetics of co trimazine sulfadiazine plus trimethoprim in geriatric patients

Petriev V.M.; Vatin O.E.; Prusova R.M., 1986: Pharmacokinetics of cobalt 57 bleomycetin a 5 in mice with lymphosarcoma lyo 1 under therapy with rubomycin

Guay D.R.P.; Awni W.M.; Halstenson C.E.; Findlay J.W.A.; Opsahl J.A.; Abraham P.A.; Jones E.C.; Matzke G.R., 1987: Pharmacokinetics of codeine after single and multiple oral dose administration to normal volunteers

Muller H.; Gips H.; Krumholz W.; Zierski J.; Lueben V.; Hempelmann G., 1986: Pharmacokinetics of continuous peridural morphine infusion

Stead R.J.; Grimmer S.F.M.; Rogers S.M.; Back D.J.; Orme M.L.; Hodson M.E.; Batten J.C., 1987: Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis

Gupta S.K.; Legg B.; Solomon L.R.; Johnson R.W.G.; Rowland M., 1987: Pharmacokinetics of cyclosporin influence of rate of constant intravenous infusion in renal transplant patients

Wenk M.; Bindschedler M.; Costa E.; Zuber M.; Vozeh S.; Thiel G.; Abisch E.; Keller H.P.; Beveridge T.; Follath F., 1988: Pharmacokinetics of cyclosporine g in patients with renal failure

Servin A.L.; Goulinet S.; Renault H., 1988: Pharmacokinetics of cysteine ethyl ester in rat

Kalenikova E.I.; Dmitrieva O.F.; Korobov N.V.; Zhukovskii S.V.; Tishchenko V.A.; Vinogradov V.A., 1988: Pharmacokinetics of dalargin

Maniez Devos D.M.; Baurain R.; Trouet A.; Lesne M., 1986: Pharmacokinetics of daunorubicinol in the rabbit comparison with daunorubicin

Rulin V.A.; Mazur N.A.; Zaitseva T.M., 1988: Pharmacokinetics of deacetyllappaconitine

Leuschner J.T.A.; Harvey D.J.; Bullingham R.E.S.; Paton W.D.M., 1986: Pharmacokinetics of delta 9 tetrahydrocannabinol in rabbits following single or multiple intravenous doses

Dol F.; Houin G.; Dupouy D.; Cadroy Y.; Caranobe C.; Gabaig A.M.; Mardiguian J.; Sie P.; Boneu B., 1988: Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection

Allain P.; Chaleil D.; Mauras Y.; Beaudeau G.; Varin M.C.; Poignet J.L.; Ciancioni C.; Ang K.S.; Cam G.; Simon P., 1987: Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on hemodialysis

Allain P.; Chaleil D.; Mauras Y.; Varin M.C.; Ang K.S.; Cam G.; Simon P., 1988: Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis

Rohdewald P.; Moellmann H.; Barth J.; Rehder J.; Derendorf H., 1987: Pharmacokinetics of dexamethasone and its phosphate ester

Silvasti M.; Karttunen P.; Tukiainen H.; Kokkonen P.; Hanninen U.; Nykanen S., 1987: Pharmacokinetics of dextromethorphan and dextrorphan a single dose comparison of three preparations in human volunteers

Locniskar A.; Greenblatt D.J.; Zinny M.A., 1986: Pharmacokinetics of dezocine a new analgesic effect of dose and route of administration

Coppock R.W.; Swanson S.P.; Gelberg H.B.; Kortiz G.D.; Buck W.B.; Hoffmann W.E., 1987: Pharmacokinetics of diacetoxyscirpenol in cattle and swine effects of halothane

Wichlinski L.M.; Mazur R.; Sieradzki E.; Jankowski A.; Dirska R.; Gosk Kowalska T., 1985: Pharmacokinetics of diazepam after intravenous intramuscular and oral administration to humans

Driessen J.J.; Vree T.B.; Van De Pol F.; Crul J.F., 1987: Pharmacokinetics of diazepam and four 3 hydroxybenzodiazepines in the cat

Lowry K.G.; Dundee J.W.; Mcclean E.; Lyons S.M.; Carson I.W.; Orr I.A., 1985: Pharmacokinetics of diazepam and midazolam when used for sedation following cardiopulmonary bypass

Silvestri T.M.; Wills R.J., 1988: Pharmacokinetics of diazepam during multiple dosing of a 6 mg controlled release capsule once daily

Bjornsson T.D.; Schold S.C.; Friedman H.S.; Schneider D.; Falletta J.M., 1985: Pharmacokinetics of diaziquone after three different dosage regimens

Courcol R.J.; Loeuille G.A.; Delnatte J.; Martin G.R., 1985: Pharmacokinetics of dibekacin in children with cystic fibrosis

Kelley S.L.; Peters W.P.; Anderson J.; Furlong E.A.; Frei E.IIi; Henner W.D., 1986: Pharmacokinetics of dibromodulcitol in humans a phase i study

Makary M.H.; Street J.C.; Sharma R.P., 1986: Pharmacokinetics of dicamba isomers applied dermally to rats

Derendorf H.; Mullersman G.; Barth J.; Gruener A.; Moellmann H., 1986: Pharmacokinetics of diclofenac sodium after intramuscular administration in combination with triamcinolone acetate

Nordberg G.; Hansdottir V.; Kvist L.; Mellstrand T.; Hedner T., 1987: Pharmacokinetics of different epidural sites of morphine administration

Opdycke J.C.; Menzer R.E., 1984: Pharmacokinetics of diflubenzuron in 2 types of chickens

Yakovlev S.V.; Glezer M.G.; Kholodov L.E.; Mikhailov A.A.; Grigro'eva E.A.; Dorokhov V.V.; Simonov V.I., 1986: Pharmacokinetics of digoxin in elderly and senile patients with subacute myocardial infarction

Schran H.F.; Tse F.L.S., 1985: Pharmacokinetics of dihydroergotamine following subcutaneous administration in humans

Vladimirskii M.A.; Ladygina G.A.; Stepanov V.M., 1984: Pharmacokinetics of dihydrostreptomycin administered intravenously in the form of a liposomal preparation in the blood serum and tissues of intact mice and mice with generalized tuberculosis

Grech Belanger O.; Langlois S.; Leboeuf E., 1988: Pharmacokinetics of diltiazem in patients undergoing continuous ambulatory peritoneal dialysis

Blyden G.T.; Greenblatt D.J.; Scavone J.M.; Shader R.I., 1986: Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration

Asmardi G.; Jamali F., 1985: Pharmacokinetics of dipyrone in man role of the administration route

Liedholm H.; Liden A.; Kroon L.; Melander A.; Wahlin Boll E., 1985: Pharmacokinetics of dixyrazine low bioavailability improved by food intake

Swagzdis J.E.; Wittendorf R.W.; Demarinis R.M.; Mico B.A., 1986: Pharmacokinetics of dopamine 2 agonists in rats and dogs

Yu D.K.; Dimmitt D.C.; Lanman R.C.; Giesing D.H., 1986: Pharmacokinetics of dothiepin in humans a single dose dose proportionality study

Beaudry M.A.; Bradley J.M.; Gramlich L.M.; Legatt D., 1988: Pharmacokinetics of doxapram in idiopathic apnea of prematurity

Fujita, H.; Ogawa, K.; Tone, H.; Iguchi, H.; Shomura, T.; Murata, S., 1986: Pharmacokinetics of doxorubicin 2 r 4' o tetrahydropyranyladriamycin and aclarubicin

Johansen P.B.; Jensen S.E.; Rasmussen S.N.; Dalmark M., 1984: Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine

Krarup Hansen A.; Wassermann K.; Rasmussen S.N.; Dalmark M., 1988: Pharmacokinetics of doxorubicin in man with induced acid or alkaline urine

Robert J.; Bui N.B.; Vrignaud P., 1987: Pharmacokinetics of doxorubicin in sarcoma patients

Wilson R.C.; Kemp D.T.; Kitzman J.V.; Goetsch D.D., 1988: Pharmacokinetics of doxycycline in dogs

Esteve A.; Martinez L.; Roser R.; Sagarra R., 1986: Pharmacokinetics of droxicam in rat and dog

Hermann T.; Chrzanowski M.; Michalewska D.; Skibinska L., 1985: Pharmacokinetics of elimination of 6 mercaptopurine in the urine of children with acute lymphoblastic leukemia

Kelly J.G.; Doyle G.; Donohue J.; Laher M.; Vandenburg M.J.; Currie W.J.C.; Cooper W.D., 1986: Pharmacokinetics of enalapril in normal subjects and patients with renal impairment

Wijnands W.J.A.; Vree T.B.; Baars A.M.; Van Herwaarden C.L.A., 1988: Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue

Watson W.T.A.; Simons K.J.; Simons F.E.R., 1988: Pharmacokinetics of enprofylline administered intravenously and as a sustained release tablet at steady state in children with asthma

Lunell E.; Borga O., 1987: Pharmacokinetics of enprofylline in healthy elderly subjects

Cerletti C.; Marchi S.; Lauri D.; Domanin M.; Lorenzi G.; Urso R.; Dejana E.; Latini R.; De Gaetano G., 1987: Pharmacokinetics of enteric coated aspirin and inhibition of platelet thromboxane a 2 and vascular prostacyclin generation in humans

Sjostrom S.; Hartvig P.; Persson M.P.; Tamsen A., 1987: Pharmacokinetics of epidural morphine and meperidine in humans

Sanders S.W.; Haering N.; Mosberg H.; Jaeger H., 1986: Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing

Disse B.; Gundert Remy U.; Weber E.; Andrassy K.; Sietzen W.; Lang A., 1986: Pharmacokinetics of erythromycin in patients with different degrees of renal impairment

Barre J.; Mallat A.; Rosenbaum J.; Deforges L.; Houin G.; Dhumeaux D.; Tillement J P., 1987: Pharmacokinetics of erythromycin in patients with severe cirrhosis respective influence of decreased serum binding and impaired liver metabolic capacity

Fu J S.; Lertora J.J.L.; Brookins J.; Rice J.C.; Fisher J.W., 1988: Pharmacokinetics of erythropoietin in intact and anephric dogs

De Bruijn N.P.; Reves J.G.; Croughwell N.; Clements F.; Drissel D.A., 1987: Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy

Buchi K.N.; Rollins D.E.; Tolman K.G.; Achari R.; Drissel D.; Hulse J.D., 1987: Pharmacokinetics of esmolol in hepatic disease


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close